id stringlengths 2 20 | ch_id stringlengths 2 20 | keywords listlengths 0 162 | title stringlengths 0 130 | authors stringlengths 0 245 | abstract stringlengths 0 4.05k | content stringlengths 0 197k | references listlengths 0 142 | created_date stringlengths 0 10 | updated_date stringlengths 0 10 | revised_date stringlengths 0 10 | journal stringclasses 1
value | source_url stringclasses 1
value | publication_types listlengths 2 2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cpt2 | cpt2 | [
"CPT II Deficiency",
"CPT II Deficiency",
"Carnitine O-palmitoyltransferase 2, mitochondrial",
"CPT2",
"Carnitine Palmitoyltransferase II Deficiency"
] | Carnitine Palmitoyltransferase II Deficiency | Thomas Wieser | Summary Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former t... | ## Diagnosis
Carnitine palmitoyltransferase II (CPT II) deficiency
Episodes of liver failure with hypoketotic hypoglycemia
Cardiomyopathy
Cardiac arrhythmias
Seizures and coma after fasting or infection
Facial abnormalities or structural malformations (e.g., cystic renal dysplasia, neuronal migration defects or... | [] | 27/8/2004 | 16/3/2017 | 3/1/2019 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
cranio-md | cranio-md | [
"Mineralization regulator ANKH",
"ANKH",
"Autosomal Dominant Craniometaphyseal Dysplasia"
] | Autosomal Dominant Craniometaphyseal Dysplasia | Ernst Reichenberger, I-Ping Chen | Summary Autosomal dominant craniometaphyseal dysplasia (AD-CMD) is characterized by progressive diffuse hyperostosis of cranial bones evident clinically as wide nasal bridge, fullness of the paranasal tissue, hypertelorism with an increase in bizygomatic width, and prominent mandible. Development of dentition may be de... | ## Diagnosis
Formal diagnostic criteria for autosomal dominant craniometaphyseal dysplasia (AD-CMD) have not been established.
AD-CMD
Obstruction of the nasal sinuses
Characteristic facial features. Wide nasal bridge, fullness of the paranasal tissue, hypertelorism with an increase in bizygomatic width, and promi... | [] | 27/8/2007 | 14/8/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
craniosynostosis | craniosynostosis | [
"FGFR Acrocephalosyndactyly",
"FGFR Acrocephalosyndactyly",
"FGFR2-Related Craniosynostosis",
"FGFR1-Related Craniosynostosis",
"FGFR3-Related Craniosynostosis",
"Fibroblast growth factor receptor 1",
"Fibroblast growth factor receptor 2",
"Fibroblast growth factor receptor 3",
"FGFR1",
"FGFR2",
... | Tara Wenger, Danny Miller, Kelly Evans | Summary The purpose of this overview is to: Describe the Review the Provide an Summarize current Inform | ## Clinical Characteristics of
To date, more than 500 individuals with an
Apert syndrome
Beare-Stevenson cutis gyrata syndrome
Bent bone dysplasia
Crouzon syndrome
Crouzon syndrome with acanthosis nigricans
Jackson-Weiss syndrome
Muenke syndrome
Pfeiffer syndrome
Isolated coronal synostosis
Considerable ph... | [] | 20/10/1998 | 16/4/2020 | 30/4/2020 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
creatine | creatine | [
"Cerebral Creatine Deficiency Disorders",
"Cerebral Creatine Deficiency Disorders",
"Guanidinoacetate Methyltransferase (GAMT) Deficiency",
"Creatine Transporter (CRTR) Deficiency",
"L-Arginine:Glycine Amidinotransferase (AGAT) Deficiency",
"Glycine amidinotransferase, mitochondrial",
"Guanidinoacetate ... | Creatine Deficiency Disorders | Saadet Mercimek-Andrews, Gajja S Salomons | Summary The creatine deficiency disorders (CDDs), inborn errors of creatine metabolism and transport, comprise three disorders: the creatine biosynthesis disorders guanidinoacetate methyltransferase (GAMT) deficiency and L-arginine:glycine amidinotransferase (AGAT) deficiency; and creatine transporter (CRTR) deficiency... | Guanidinoacetate methyltransferase (GAMT) deficiency
L-arginine:glycine amidinotransferase (AGAT) deficiency
Creatine transporter (CRTR) deficiency
• Guanidinoacetate methyltransferase (GAMT) deficiency
• L-arginine:glycine amidinotransferase (AGAT) deficiency
• Creatine transporter (CRTR) deficiency
## Diagnosis... | [] | 15/1/2009 | 10/2/2022 | 7/8/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
csc-dys | csc-dys | [
"Decorin",
"DCN",
"Congenital Stromal Corneal Dystrophy"
] | Congenital Stromal Corneal Dystrophy | Eyvind Rødahl, Per M Knappskog, Cecilie Bredrup, Helge Boman | Summary Congenital stromal corneal dystrophy is characterized by the presence of bilateral corneal opacities that can be seen at or shortly after birth. The surface of the cornea is normal or slightly irregular; small opacities are seen throughout the stroma of the entire cornea and give the cornea a cloudy appearance.... | ## Diagnosis
Congenital stromal corneal dystrophy (CSCD)
The surface of the cornea is normal or slightly irregular.
Small opacities are seen throughout the stroma of the entire cornea and give the cornea a cloudy appearance.
The thickness of the cornea (as measured by ultrasonic pachymetry) is increased. Note: This... | [
"BT Acar, KT Bozkurt, E Duman, S Acar. Bilateral cloudy cornea: is the usual suspect congenital hereditary endothelial dystrophy or stromal dystrophy?. BMJ Case Rep 2016:2016",
"C Bredrup, PM Knappskog, J Majewski, E Rødahl, H Boman. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin g... | 25/11/2008 | 29/11/2018 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
csnb | csnb | [
"X-Linked CSNB",
"X-Linked CSNB",
"Nyctalopin",
"Voltage-dependent L-type calcium channel subunit alpha-1F",
"CACNA1F",
"NYX",
"X-Linked Congenital Stationary Night Blindness"
] | X-Linked Congenital Stationary Night Blindness | Ian M MacDonald, Stephanie Hoang, Sari Tuupanen | Summary X-linked congenital stationary night blindness (CSNB) is characterized by non-progressive retinal findings of reduced visual acuity ranging from 20/30 to 20/200; defective dark adaptation; refractive error, most typically myopia ranging from low (-0.25 diopters [D] to -4.75 D) to high (≥-10.00 D) but occasional... | ## Diagnosis
Characteristic clinical findings:
Reduced visual acuity
Night blindness
Myopia
Nystagmus (not universal) and strabismus (50%-70%)
Normal color vision
Normal fundus examination
Family history consistent with X-linked inheritance
Characteristic findings on ERG examination:
ERG is used to assess the... | [
"LE Allen, I Zito, K Bradshaw, RJ Patel, AC Bird, F Fitzke, JR Yates, D Trump, AJ Hardcastle, AT Moore. Genotype-phenotype correlation in British families with X linked congenital stationary night blindness.. Br J Ophthalmol 2003;87:1413-20",
"NT Bech-Hansen, MJ Naylor, TA Maybaum, WG Pearce, B Koop, GA Fishman, ... | 16/1/2008 | 3/7/2019 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
csnk2b-ndd | csnk2b-ndd | [
"Poirier-Bienvenu Neurodevelopmental Syndrome (POBINDS)",
"Poirier-Bienvenu Neurodevelopmental Syndrome (POBINDS)",
"Casein kinase II subunit beta",
"CSNK2B",
"CSNK2B-Related Neurodevelopmental Disorder"
] | Natalie Lippa, Maureen Mulhern, Michelle Ernst Florido, Chelsea Earley, Tristan T Sands | Summary The diagnosis of | ## Diagnosis
No consensus clinical diagnostic criteria for
Mild-to-profound developmental delay (DD), intellectual disability (ID), or learning disability
Epilepsy ranging from mild pharmaco-responsive epilepsy to severe intractable epilepsy with recurrent status epilepticus. Seizure types include the following:
... | [] | 5/9/2024 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
ctcf-dis | ctcf-dis | [
"Autosomal Dominant Intellectual Disability 21",
"CTCF-Related Neurodevelopmental Disorder",
"Autosomal Dominant Intellectual Disability 21",
"CTCF-Related Neurodevelopmental Disorder",
"Transcriptional repressor CTCF",
"CTCF",
"CTCF-Related Disorder"
] | Hannah Gabriela Valverde de Morales, Hsiao-Lin Wang, Kathryn Garber, Victor Corces, Hong Li | Summary The diagnosis of | ## Diagnosis
No consensus clinical diagnostic criteria for
Mild-to-profound developmental delay (DD) or intellectual disability (ID)
AND
Any of the following features presenting in infancy or childhood:
Hypotonia
Feeding difficulties
Slow growth
Neurobehavioral/psychiatric manifestations, including autism spe... | [] | 25/4/2024 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
ctlm | ctlm | [
"Argininosuccinate Synthetase Deficiency",
"Argininosuccinic Acid Synthetase Deficiency",
"ASS Deficiency",
"Classic Citrullinemia",
"CTLN1",
"ASS Deficiency",
"Classic Citrullinemia",
"CTLN1",
"Argininosuccinic Acid Synthetase Deficiency",
"Argininosuccinate Synthetase Deficiency",
"Argininosuc... | Citrullinemia Type I | Shane C Quinonez, Kristen N Lee | Summary Citrullinemia type I (CTLN1) presents as a spectrum that includes a neonatal acute form (the "classic" form), a milder late-onset form (the "non-classic" form), a form in which women have onset of symptoms at pregnancy or post partum, and a form without symptoms or hyperammonemia. Distinction between the forms ... | ## Diagnosis
Citrullinemia type I (CTLN1) results from deficiency of the enzyme argininosuccinate synthase, the third step in the urea cycle, in which citrulline is condensed with aspartate to form arginosuccinic acid (see Urea Cycle Disorders Overview
NBS for CTLN1 is primarily based on quantification of the analyte... | [] | 7/7/2004 | 18/8/2022 | 22/4/2008 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
ctnnb1-ndd | ctnnb1-ndd | [
"Catenin beta-1",
"CTNNB1",
"CTNNB1 Neurodevelopmental Disorder"
] | Stephanie KL Ho, Mandy HY Tsang, Mianne Lee, Shirley SW Cheng, Ho-ming Luk, Ivan FM Lo, Brian HY Chung | Summary The diagnosis of | ## Diagnosis
No consensus clinical diagnostic criteria for
Mild-to-profound developmental delay or intellectual disability
Exudative vitreoretinopathy with a range of findings observed in familial exudative vitreoretinopathy (FEVR) that include: asymptomatic peripheral retina avascularity, neovascularization, and fi... | [
"RG Coussa, Y Zhao, MJ DeBenedictis, A Babiuch, J Sears, EI Traboulsi. Novel mutation in CTNNB1 causes familial exudative vitreoretinopathy (FEVR) and microcephaly: case report and review of the literature.. Ophthalmic Genet. 2020;41:63-8",
"J de Ligt, MH Willemsen, BW van Bon, T Kleefstra, HG Yntema, T Kroes, AT... | 19/5/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
ctns | ctns | [
"Non-Nephropathic (Ocular) Cystinosis",
"Later-Onset (Juvenile) Cystinosis",
"Nephropathic Cystinosis",
"Cystinosin",
"CTNS",
"Cystinosis"
] | Cystinosis | William A Gahl | Summary Cystinosis comprises three allelic clinical phenotypes caused by pathogenic variants in The diagnosis of cystinosis is established in a proband with cystine crystals in the cornea identified on slit lamp examination, elevated cystine concentration in polymorphonuclear leukocytes, and/or demonstration of increas... | Nephropathic cystinosis
Later-onset (juvenile) cystinosis
Non-nephropathic (ocular) cystinosis
For synonyms and outdated names see
• Nephropathic cystinosis
• Later-onset (juvenile) cystinosis
• Non-nephropathic (ocular) cystinosis
## Diagnosis
Typically, birth weight and initial growth are normal. Poor weigh... | [] | 22/3/2001 | 14/8/2025 | 7/12/2017 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
ctx | ctx | [
"Sterol 26-hydroxylase, mitochondrial",
"CYP27A1",
"Cerebrotendinous Xanthomatosis"
] | Cerebrotendinous Xanthomatosis | Antonio Federico, Gian Nicola Gallus | Summary Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease characterized by infantile-onset diarrhea, childhood-onset cataract, adolescent- to young adult-onset tendon xanthomas, and adult-onset progressive neurologic dysfunction (dementia, psychiatric disturbances, pyramidal and/or cerebellar signs, dysto... | ## Diagnosis
A consensus paper on the diagnostic criteria and management of cerebrotendinous xanthomatosis (CTX) has been published [
CTX, a lipid storage disease,
Neonatal cholestasis
Infantile-onset diarrhea
Childhood-onset cataract
Adolescent- to young adult-onset tendon xanthomas (
Adult-onset progressive ... | [] | 16/7/2003 | 17/3/2022 | 14/11/2024 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
cutis-laxa | cutis-laxa | [
"ATP6V0A2-CDG",
"Autosomal Recessive Cutis Laxa Type 2A (ARCL2A)",
"Autosomal Recessive Cutis Laxa Type 2A (ARCL2A)",
"ATP6V0A2-CDG",
"Debré-Type Cutis Laxa",
"Wrinkly Skin Syndrome",
"V-type proton ATPase 116 kDa subunit a 2",
"ATP6V0A2",
"ATP6V0A2-Related Cutis Laxa"
] | Lionel Van Maldergem, William Dobyns, Uwe Kornak | Summary The diagnosis of | Debré-type cutis laxa
Wrinkly skin syndrome
• Debré-type cutis laxa
• Wrinkly skin syndrome
## Diagnosis
Furrowing of the skin of the whole body; particularly obvious in neck, axillae, and groin
Skin that when extended does not display marked hyperelasticity (as is observed in the Ehlers-Danlos syndromes) but r... | [] | 19/3/2009 | 28/1/2021 | 16/3/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
cvt | cvt | [
"Catecholamine-Induced Polymorphic Ventricular Tachycardia",
"CPVT",
"CPVT",
"Catecholamine-Induced Polymorphic Ventricular Tachycardia",
"Calmodulin",
"Calmodulin-3",
"Calsequestrin-2",
"Inward rectifier potassium channel 2",
"Ryanodine receptor 2",
"Trans-2,3-enoyl-CoA reductase-like",
"Triadi... | Catecholaminergic Polymorphic Ventricular Tachycardia | Carlo Napolitano, Andrea Mazzanti, Raffaella Bloise, Silvia G Priori | Summary Catecholaminergic polymorphic ventricular tachycardia (CPVT) is characterized by episodic syncope occurring during exercise or acute emotion. The underlying cause of these episodes is the onset of fast ventricular tachycardia (bidirectional or polymorphic). Spontaneous recovery may occur when these arrhythmias ... | ## Diagnosis
Catecholaminergic polymorphic ventricular tachycardia (CPVT)
Syncope occurring during physical activity or acute emotion; mean onset is age seven to 12 years. Less frequently, first manifestations may occur later in life; individuals with a first event up to age 40 years have been reported.
History of e... | [
"Y Aizawa, S Komura, S Okada, M Chinushi, Y Aizawa, H Morita, T Ohe. Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT).. Int Heart J 2006;47:381-9",
"SM Al-Khatib, WG Stevenson, MJ Ackerman, WJ Bryant, DJ Callans, AB Curtis, BJ Deal, T Dickfeld, ME Field, GC Fon... | 14/10/2004 | 23/6/2022 | 7/2/2013 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
cyclic-n | cyclic-n | [
"Cyclic Neutropenia",
"Congenital Neutropenia",
"Neutrophil elastase",
"ELANE",
"ELANE-Related Neutropenia"
] | David C Dale, Vahagn Makaryan | Summary In congenital neutropenia, omphalitis immediately after birth may be the first sign; in untreated children diarrhea, pneumonia, and deep abscesses in the liver, lungs, and subcutaneous tissues are common in the first year of life. After 15 years with granulocyte colony-stimulating factor treatment, the risk of ... | Congenital neutropenia
Cyclic neutropenia
For synonyms and outdated names see
For other genetic causes of these phenotypes see
• Congenital neutropenia
• Cyclic neutropenia
## Diagnosis
Mouth ulcers, pharyngitis, and fever recurring regularly at three-week intervals
Inflammation and infection of the sinus... | [
"PJ Ancliff, RE Gale, R Liesner, I Hann, DC Linch. Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy.. Br J Haematol. 2003a;120:685-90",
"PJ Ancliff, RE Gale, DC Linch. Neutrophil elastase mu... | 17/6/2002 | 23/8/2018 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
cyld-cs | cyld-cs | [
"Brooke-Spiegler Syndrome (BSS)",
"Familial Cylindromatosis (FC)",
"Multiple Familial Trichoepithelioma (MFT)",
"Multiple Familial Trichoepithelioma (MFT)",
"Familial Cylindromatosis (FC)",
"Brooke-Spiegler Syndrome (BSS)",
"Ubiquitin carboxyl-terminal hydrolase CYLD",
"CYLD",
"CYLD Cutaneous Syndro... | Anna Dubois, Neil Rajan | Summary The diagnosis of Germline pathogenic variants in | ## Diagnosis
Formal diagnostic criteria for
The presence of one or more cylindromas or spiradenomas on the face and scalp, perinasal trichoepitheliomas, or a combination of these tumor types in an individual
Cylindromas, spiradenomas, and trichoepitheliomas can be diagnosed clinically but may mimic other skin tumors... | [
"M Arefi, V Wilson, S Muthiah, S Zwolinski, D Bajwa, P Brennan, K Blasdale, D Bourn, J Burn, M Santibanez-Koref, N Rajan. Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission.. J Am Acad Dermatol. 2019;81:1300-7",
"AP Arruda, AC Cardoso-Dos-S... | 16/4/2020 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
danon | danon | [
"Lysosome-associated membrane glycoprotein 2",
"LAMP2",
"Danon Disease"
] | Danon Disease | Matthew RG Taylor, Eric D Adler | Summary Danon disease is a multisystem condition with predominant involvement of the heart, skeletal muscles, and retina, with overlying cognitive dysfunction. Males are typically more severely affected than females. Males usually present with childhood onset concentric hypertrophic cardiomyopathy that is progressive a... | ## Diagnosis
For the purposes of this
Danon disease is a multisystem condition with predominant involvement of the heart, skeletal muscles, and retina, with overlying cognitive dysfunction. Formal clinical diagnostic criteria for Danon disease have not been established.
Danon disease
Cardiomyopathy that is predom... | [] | 5/3/2020 | 23/5/2024 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dbh | dbh | [
"Dopamine beta-hydroxylase",
"DBH",
"Dopamine Beta-Hydroxylase Deficiency"
] | Dopamine Beta-Hydroxylase Deficiency | Italo Biaggioni | Summary Dopamine beta-hydroxylase (DBH) deficiency is characterized by lack of sympathetic noradrenergic function resulting in profound deficits in autonomic regulation of cardiovascular function (orthostatic hypotension) and other autonomic dysfunction (ptosis, nasal stuffiness, sleep difficulties, and impaired ejacul... | ## Diagnosis
No consensus clinical diagnostic criteria have been published for dopamine beta-hydroxylase (DBH) deficiency. A clinical assessment including orthostatic vital signs and an ophthalmic exam should be the initial step; if indicated, this should be followed by autonomic function testing and plasma catecholam... | [] | 4/9/2003 | 26/9/2024 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dbmd | dbmd | [
"Duchenne Muscular Dystrophy (DMD)",
"Becker Muscular Dystrophy (BMD)",
"DMD-Associated Dilated Cardiomyopathy",
"Dystrophin",
"DMD",
"Dystrophinopathies"
] | Dystrophinopathies | Basil T Darras, David K Urion, Partha S Ghosh | Summary The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker muscular dystrophy, and Duchenne muscular dystrophy (DMD) usually presents in early childhood with delayed motor milestones including delays in walking independently a... | Duchenne muscular dystrophy (DMD)
Becker muscular dystrophy (BMD)
For synonyms and outdated names see
For other genetic causes of these phenotypes see
• Duchenne muscular dystrophy (DMD)
• Becker muscular dystrophy (BMD)
## Diagnosis
The dystrophinopathies cover a spectrum of X-linked muscle disease that ranges ... | [
"A Aartsma-Rus, JC Van Deutekom, IF Fokkema, GJ Van Ommen, JT Den Dunnen. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.. Muscle Nerve 2006;34:135-44",
"A Aartsma-Rus, I Fokkema, J Verschuuren, I Ginjaar... | 5/9/2000 | 26/4/2018 | 20/1/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dcm-lmna | dcm-lmna | [
"Prelamin-A/C",
"LMNA",
"LMNA-Related Dilated Cardiomyopathy"
] | Ray E Hershberger, Elizabeth Jordan | Summary The diagnosis of | ## Diagnosis
The diagnosis of
Note: Identification of a heterozygous
Because the phenotype of
Note: Single-gene testing (sequence analysis of
For an introduction to multigene panels click
For an introduction to comprehensive genomic testing click
Molecular Genetic Testing Used in
See
See
Sequence analysis d... | [] | 12/6/2008 | 17/3/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
dcm-ov | dcm-ov | [
"DMD-Related Dilated Cardiomyopathy",
"LDB3-Related Dilated Cardiomyopathy",
"LMNA-Related Dilated Cardiomyopathy",
"MYBPC3-Related Dilated Cardiomyopathy",
"MYH7-Related Dilated Cardiomyopathy",
"PLN-Related Dilated Cardiomyopathy",
"SCN5A-Related Dilated Cardiomyopathy",
"SGCD-Related Dilated Cardio... | Dilated Cardiomyopathy Overview | Ray E Hershberger, Elizabeth Jordan | Summary The purpose of this overview is to: Identify the Provide the Provide a basic view of | ## Dilated Cardiomyopathy (DCM): Definition
The diagnosis of DCM is established when both of the following are present:
Note:
DCM usually initially manifests in adults in the fourth to sixth decade, although it may present at any age (prenatally; in infancy, early or late childhood, or adolescence; or in the elderl... | [] | 27/7/2007 | 29/7/2021 | 12/12/2024 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dcx | dcx | [
"DCX-Related Classic Lissencephaly",
"DCX-Related Subcortical Band Heterotopia (SBH)",
"Neuronal migration protein doublecortin",
"DCX",
"DCX-Related Disorders"
] | Tobias Geis, Gökhan Uyanik, Ludwig Aigner, Sebastien Couillard-Despres, Jürgen Winkler, Ute Hehr | Summary The diagnosis of a | Classic lissencephaly
Subcortical band heterotopia (SBH)
For synonyms and outdated names see
For other genetic causes of these phenotypes, see
• Classic lissencephaly
• Subcortical band heterotopia (SBH)
## Diagnosis
For the purposes of this
Classic thick lissencephaly, primarily in males
Subcortical band hete... | [] | 19/10/2007 | 5/6/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
ddon | ddon | [
"DDON",
"Mohr-Tranebjaerg Syndrome",
"Mohr-Tranebjaerg Syndrome",
"Mitochondrial import inner membrane translocase subunit Tim8 A",
"TIMM8A",
"Deafness-Dystonia-Optic Neuronopathy Syndrome"
] | Deafness-Dystonia-Optic Neuronopathy Syndrome | Lisbeth Tranebjærg | Summary Males with deafness-dystonia-optic neuronopathy (DDON) syndrome have prelingual or postlingual sensorineural hearing impairment in early childhood, slowly progressive dystonia or ataxia in the teens, slowly progressive decreased visual acuity from optic atrophy beginning at approximately age 20 years, and demen... | ## Diagnosis
Formal diagnostic criteria for deafness-dystonia-optic neuronopathy (DDON) syndrome have not been established.
Deafness-dystonia-optic neuronopathy (DDON) syndrome is suspected in males with the following:
Progressive sensorineural hearing impairment with prelingual or postlingual onset:
Absent stapedi... | [
"T Arai, M Zhao, H Kanegane, MC van Zelm, T Futatani, M Yamada, T Ariga, HD Ochs, T Miyawaki, T Oh-ishi. Genetic analysis of contiguous nX-chromosome deletion syndrome encompassing the BTK and TIMM8A genes.. J Hum Genet 2011;56:577-82",
"F Bahmad, SN Merchant, JB Nadol, L Tranebjaerg. Otopathology in Mohr-Tranebj... | 6/2/2003 | 21/11/2019 | 24/3/2009 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
ddx3x-ndd | ddx3x-ndd | [
"ATP-dependent RNA helicase DDX3X",
"DDX3X",
"DDX3X-Related Neurodevelopmental Disorder"
] | Bethany Johnson-Kerner, Lot Snijders Blok, Lindsey Suit, Julian Thomas, Tjitske Kleefstra, Elliott H Sherr | Summary The diagnosis of If the proband is female and represents a simplex case and if the Once the | ## Diagnosis
Formal diagnostic criteria for
Developmental delay (DD) or mild to severe intellectual disability (ID)
Hypotonia (primarily truncal)
Behavior problems: autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), inappropriate behavior, self-injurious behavior, poor impulse contro... | [
"L Basel-Vanagaite, R Yilmaz, S Tang, MS Reuter, N Rahner, DK Grange, M Mortenson, P Koty, H Feenstra, KD Farwell Gonzalez, H Sticht, N Boddaert, J Désir, K Anyane-Yeboa, C Zweier, A Reis, C Kubisch, T Jewett, W Zeng, G Borck. Expanding the clinical and mutational spectrum of Kaufman oculocerebrofacial syndrome wit... | 27/8/2020 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
ddx41-mds | ddx41-mds | [
"DDX41-Related Myeloid Neoplasia",
"Myeloid Neoplasms with Germline DDX41 Mutation",
"DDX41-Related Myeloid Neoplasia",
"Myeloid Neoplasms with Germline DDX41 Mutation",
"Probable ATP-dependent RNA helicase DDX41",
"DDX41",
"DDX41-Associated Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia"
... | Jane E Churpek, Kelcy Smith-Simmer | Summary The diagnosis of | ## Diagnosis
Less common myeloid neoplasms include chronic myelomonocytic leukemia, chronic myeloid leukemia, and myeloproliferative neoplasms.
Unexplained blood count abnormalities including mild single- or multiple-lineage cytopenias and/or macrocytosis (in 40%-66%)
In individuals with MDS/AML:
Bone marrow hy... | [
"I Abou Dalle, H Kantarjian, SA Bannon, R Kanagal-Shamanna, M Routbort, KP Patel, S Hu, K Bhalla, G Garcia-Manero, CD DiNardo. Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation.. Am J Hematol. 2020;95:227-9",
"DA Arber, A Orazi, R Hasserjian, J Thiele, MJ Borowit... | 28/10/2021 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
deafness-overview | deafness-overview | [
"Nonsyndromic Hearing Loss and Deafness",
"Actin, cytoplasmic 2",
"Alpha-tectorin",
"Barttin",
"Cadherin-23",
"Claudin-14",
"Cochlin",
"Coiled-coil domain-containing protein 50",
"Collagen alpha-2(XI) chain",
"Cytochrome c oxidase subunit 1",
"Dentin sialophosphoprotein",
"Endosomal transmembr... | Genetic Hearing Loss Overview | A Eliot Shearer, Michael S Hildebrand, Amanda M Odell, Richard JH Smith | Summary The purpose of this Describe the Review the Review the Explain the Review the Inform the | ## Audiometric and Clinical Aspects of Hearing Loss
Hearing loss can be characterized by type, onset, severity, and frequency.
Conductive hearing loss, due to abnormalities of the external ear and/or the ossicles of the middle ear
Sensorineural hearing loss due to malfunction of the inner ear structures (i.e., co... | [] | 14/2/1999 | 6/4/2023 | 3/4/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
del16p11_2 | del16p11_2 | [
"Not applicable",
"Not applicable",
"16p11.2 Recurrent Deletion"
] | 16p11.2 Recurrent Deletion | Cora M Taylor, Rebecca Smith, Christopher Lehman, Marissa W Mitchel, Kaitlyn Singer, W Curtis Weaver, Wendy Chung | Summary The 16p11.2 recurrent deletion phenotype is characterized by motor speech disorder, language disorder, motor coordination difficulties, psychiatric conditions, and autistic features. While most, if not all, individuals with the 16p11.2 recurrent deletion experience some degree of developmental delay, the severi... | ## Diagnosis
The 16p11.2 recurrent deletion
Motor speech disorder, especially childhood apraxia of speech
Language disorder
Learning difficulties / intellectual disability
Social impairments with or without a diagnosis of autism spectrum disorder (ASD)
Macrocephaly
Chiari I malformation / cerebellar tonsillar ec... | [] | 22/9/2009 | 28/10/2021 | 27/10/2011 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
del1p36 | del1p36 | [
"Monosomy 1p36 Syndrome",
"Monosomy 1p36 Syndrome",
"Not applicable",
"Not applicable",
"1p36 Deletion Syndrome"
] | 1p36 Deletion Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | Agatino Battaglia | Summary 1p36 deletion syndrome is characterized by typical craniofacial features consisting of straight eyebrows, deeply set eyes, midface retrusion, wide and depressed nasal bridge, long philtrum, pointed chin, large, late-closing anterior fontanel (77%), microbrachycephaly (65%), epicanthal folds (50%), and posterio... | ## Diagnosis
The diagnosis of 1p36 deletion syndrome is suggested by the characteristic facial appearance, hypotonia, psychomotor retardation, and poor or absent speech and is confirmed by detection of a deletion of the most distal band of the short arm of chromosome 1 (1p36).
An apparently "pure" terminal deletion
... | [
"J Anderson, H Kempski, L Hill, D Rampling, T Gordon, A Michalski. Neuroblastoma in monozygotic twins--a case of probable twin-to-twin metastasis.. Br J Cancer 2001;85:493-6",
"N Bahi-Buisson, E Gutierrez-Delicado, C Soufflet, M Rio, V Cormier Daire, D Lacombe, D Heron, A Verloes, SM Zuberi, L Burglen, A Afenjar,... | 1/2/2008 | 6/6/2013 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
del2q37_2 | del2q37_2 | [
"Albright Hereditary Osteodystrophy-Like Syndrome",
"Brachydactyly-Mental Retardation Syndrome",
"Albright Hereditary Osteodystrophy-Like Syndrome",
"Brachydactyly-Mental Retardation Syndrome",
"Histone deacetylase 4",
"Not applicable",
"HDAC4",
"Not applicable",
"2q37 Microdeletion Syndrome"
] | 2q37 Microdeletion Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | Emily S Doherty, Felicitas L Lacbawan | Summary 2q37 microdeletion syndrome is characterized by mild-moderate developmental delay/intellectual disability, brachymetaphalangy of digits 3-5 (often digit 4 alone) (>50%), short stature, obesity, hypotonia, characteristic facial appearance, autism or autism spectrum disorder (30%), joint hypermobility/dislocatio... | ## Diagnosis
Developmental delay/intellectual disability
Brachymetaphalangy of digits 3-5 (often digit 4 alone), referred to as type E brachydactyly
Short stature
Obesity
Hypotonia
Characteristic facial appearance:
Round face (variable)
Frontal bossing
Arched eyebrows
Deep-set eyes
Upslanted palpebral fissur... | [
"MA Aldred. Genetics of pseudohypoparathyroidism types Ia and Ic.. J Pediatr Endocrinol Metab 2006;19:635-40",
"MA Aldred, RO Sanford, NS Thomas, MA Barrow, LC Wilson, LA Brueton, MC Bonaglia, RC Hennekam, C Eng, NR Dennis, RC Trembath. Molecular analysis of 20 patients with 2q37.3 monosomy: definition of minimum... | 3/5/2007 | 9/8/2012 | 31/1/2013 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dent | dent | [
"H(+)/Cl(-) exchange transporter 5",
"Inositol polyphosphate 5-phosphatase OCRL",
"CLCN5",
"OCRL",
"Dent Disease"
] | Dent Disease | John C Lieske, Dawn S Milliner, Lada Beara-Lasic, Peter Harris, Andrea Cogal, Elizabeth Abrash | Summary Dent disease, an X-linked disorder of proximal renal tubular dysfunction, is characterized by low molecular weight (LMW) proteinuria, hypercalciuria, and at least one additional finding including nephrocalcinosis, nephrolithiasis, hematuria, hypophosphatemia, chronic kidney disease (CKD), and evidence of X-link... | ## Diagnosis
Dent disease
LMW proteinuria (the pathognomonic finding of Dent disease) at least five times (and often 10x) above the upper limit of normal. Commonly screened LMW proteins are retinol binding protein and α1 microglobulin.
Note: β2 microglobulin is also often measured to screen for LMW proteinuria. To t... | [] | 9/8/2012 | 14/12/2017 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
depdc5-epilepsy | depdc5-epilepsy | [
"DEPDC5-Related Familial Focal Epilepsy with Variable Foci (FFEVF)",
"DEPDC5-Related Autosomal Dominant Sleep-Related Hypermotor Epilepsy (ADSHE) (Autosomal Dominant Nocturnal Frontal Lobe Epilepsy [ADNFLE])",
"DEPDC5-Related Familial Mesial Temporal Lobe Epilepsy (FMTLE)",
"DEPDC5-Related Autosomal Dominant ... | Stéphanie Baulac, Sara Baldassari | Summary The diagnosis of | Familial focal epilepsy with variable foci (FFEVF)
Autosomal dominant sleep-related hypermotor epilepsy (ADSHE) (previously termed autosomal dominant nocturnal frontal lobe epilepsy [ADNFLE])
Familial mesial temporal lobe epilepsy (FMTLE)
Autosomal dominant epilepsy with auditory features (ADEAF)
Infantile spasms
... | [
"C Arenas-Cabrera, P Baena-Palomino, J Sánchez-García, M Oliver-Romero, Y Chocrón-González, M Caballero-Martínez. Sleep-related hypermotor epilepsy with genetic diagnosis: description of a case series in a tertiary referral hospital.. J Cent Nerv Syst Dis. 2022;14",
"A Bacq, D Roussel, T Bonduelle, S Zagaglia, M ... | 29/9/2016 | 9/3/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
df-lamm | df-lamm | [
"Congenital Deafness with Inner Ear Agenesis, Microtia, and Microdontia",
"LAMM Syndrome",
"Congenital Deafness with Inner Ear Agenesis, Microtia, and Microdontia",
"LAMM Syndrome",
"Fibroblast growth factor 3",
"FGF3",
"Congenital Deafness with Labyrinthine Aplasia, Microtia, and Microdontia"
] | Congenital Deafness with Labyrinthine Aplasia, Microtia, and Microdontia | Jessica Ordonez, Mustafa Tekin | Summary Congenital deafness with The diagnosis of LAMM syndrome is established in a proband by identification of biallelic pathogenic variants in LAMM syndrome is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an as... | ## Diagnosis
The diagnosis of congenital deafness with
Profound congenital sensorineural deafness
Severe inner ear anomalies diagnosed by CT scan or MRI of the inner ear. The most common inner ear anomaly is complete labyrinthine aplasia with no recognizable structure in the inner ear (also referred to as Michel apl... | [] | 20/9/2012 | 4/4/2019 | 14/8/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dfn-myop | dfn-myop | [
"SLIT and NTRK-like protein 6",
"SLITRK6",
"Deafness and Myopia Syndrome"
] | Deafness and Myopia Syndrome – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | Jessica L Ordonez, Mustafa Tekin | Summary Deafness and myopia (DFNMYP) syndrome is characterized by bilateral, congenital or prelingual deafness (sensorineural hearing loss or auditory neuropathy spectrum disorder) and high myopia (>-6 diopters). In individuals with a molecularly confirmed diagnosis reported to date, hearing loss was progressive and s... | ## Diagnosis
Deafness and myopia (DFNMYP) syndrome
Moderate-to-profound, bilateral, congenital or prelingual sensorineural hearing loss or auditory neuropathy spectrum disorder (sensorineural hearing loss originates from problems in the inner ear or the auditory nerve). Auditory neuropathy spectrum disorder is charac... | [] | 15/1/2015 | 14/9/2017 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dfna2 | dfna2 | [
"Potassium voltage-gated channel subfamily KQT member 4",
"KCNQ4",
"DFNA2 Nonsyndromic Hearing Loss"
] | DFNA2 Nonsyndromic Hearing Loss | Richard JH Smith, Michael Hildebrand | Summary DFNA2 nonsyndromic hearing loss is characterized by symmetric, predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive across all frequencies. At younger ages, hearing loss tends to be mild in the low frequencies and moderate in the high frequencies; in older persons, the hearing loss... | ## Diagnosis
DFNA2 nonsyndromic hearing loss
Symmetric, predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive across all frequencies:
At younger ages, hearing loss tends to be mild in the low frequencies and moderate in the high frequencies.
In older persons, the hearing loss is moder... | [
"J Akita, S Abe, H Shinkawa, WJ Kimberling, S Usami. Clinical and genetic features of nonsyndromic autosomal dominant sensorineural hearing loss: KCNQ4 is a gene responsible in Japanese.. J Hum Genet 2001;46:355-61",
"PJ Coucke, P Van Hauwe, PM Kelley, H Kunst, I Schatteman, D Van Velzen, J Meyers, RJ Ensink, M V... | 4/4/2008 | 10/5/2018 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dfna3 | dfna3 | [
"GJB2-Related DFNA 3 Nonsyndromic Hearing Loss and Deafness",
"GJB6-Related DFNA 3 Nonsyndromic Hearing Loss and Deafness",
"Gap junction beta-2 protein",
"Gap junction beta-6 protein",
"GJB2",
"GJB6",
"Nonsyndromic Hearing Loss and Deafness, DFNA3"
] | Nonsyndromic Hearing Loss and Deafness, DFNA3 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | Richard JH Smith, Paul T Ranum | Summary Nonsyndromic hearing loss and deafness, DFNA3 is characterized by pre- or postlingual mild-to-profound progressive high-frequency sensorineural hearing impairment. Affected individuals have no other associated medical findings. Diagnosis of DFNA3 depends on molecular genetic testing to identify a heterozygous ... | ## Diagnosis
No formal diagnostic criteria have been published for DFNA3-related hearing loss.
Nonsyndromic hearing loss and deafness, DFNA3
Pre- or postlingual mild-to-profound progressive sensorineural hearing impairment [
Note: (1) Hearing is measured in decibels (dB). The threshold or 0 dB mark for each frequen... | [] | 28/9/1998 | 22/12/2016 | 15/7/2004 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dfnb1 | dfnb1 | [
"DFNB1",
"Gap junction beta-2 protein",
"GJB2",
"GJB2-Related Autosomal Recessive Nonsyndromic Hearing Loss"
] | Richard JH Smith, Hela Azaiez, Kevin Booth | Summary The diagnosis of Because children with severe-to-profound hearing loss who are candidates for cochlear implantation can attain levels of social functioning and education indistinguishable from those of normal-hearing peers, cochlear implantation should be performed as soon as possible. Children with mild-to-mod... | ## Diagnosis
The diagnosis of
Universal NBHS using physiologic screening (either otoacoustic emissions [OAE], which measure the response of cochlear outer hair cells to auditory stimuli, or automated auditory brain stem response [ABR], which measures the physiologic response of cochlear inner hair cells, auditory ner... | [] | 28/9/1998 | 20/7/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
dfnb9 | dfnb9 | [
"DFNB9",
"Otoferlin-Related Hearing Loss",
"DFNB9",
"Otoferlin-Related Hearing Loss",
"Typical OTOF-Related Hearing Loss",
"Atypical (Temperature Sensitive or Progressive) OTOF-Related Hearing Loss",
"Otoferlin",
"OTOF",
"OTOF-Related Hearing Loss"
] | Hela Azaiez, Ryan K Thorpe, Amanda M Odell, Richard JH Smith | Summary The two phenotypes comprising The diagnosis of | For synonyms and outdated names see
## Diagnosis
No consensus clinical diagnostic criteria for
Universal NBHS using physiologic screening is required by law or rule in all 50 states in the US and is performed on >98% of children in the US typically within days after birth (see
Temperature-sensitive
Mild-to-moderat... | [] | 29/2/2008 | 13/3/2025 | 14/6/2011 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dfnx1 | dfnx1 | [
"DFN2 Nonsyndromic Hearing Loss and Deafness",
"Ribose-phosphate pyrophosphokinase 1",
"PRPS1",
"DFNX1 Nonsyndromic Hearing Loss and Deafness"
] | DFNX1 Nonsyndromic Hearing Loss and Deafness – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | Xue Z Liu, Huijun Yuan, Rahul Mittal, Denise Yan | Summary DFNX1 nonsyndromic hearing loss and deafness is part of the spectrum of Diagnosis relies on the presence of characteristic hearing loss in males and detection of a hemizygous DFNX1 is inherited in an X-linked manner. The father of an affected male will not have the disorder nor will he be a carrier of the path... | ## Diagnosis
DFNX1 nonsyndromic hearing loss and deafness, part of the spectrum of
Sensorineural hearing loss is:
Bilateral moderate to profound;
Prelingual or postlingual in onset;
Progressive or non-progressive.
Audiograms are usually flat across all frequencies. However, some individuals have severe hearing ... | [
"B Almoguera, S He, M Corton, P Fernandez-San Jose, F Blanco-Kelly, MI López-Molina, B García-Sandoval, J Del Val, Y Guo, L Tian, X Liu, L Guan, RJ Torres, JG Puig, H Hakonarson, X Xu, B Keating, C Ayuso. Expanding the phenotype of. Orphanet J Rare Dis. 2014;9:190",
"AP de Brouwer, H van Bokhoven, SB Nabuurs, WF ... | 4/8/2011 | 19/7/2018 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dguok-mtddepl | dguok-mtddepl | [
"DGUOK Deficiency",
"DGUOK-Related Mitochondrial DNA Depletion Syndrome, Hepatocerebral Form",
"DGUOK Deficiency",
"DGUOK-Related Mitochondrial DNA Depletion Syndrome, Hepatocerebral Form",
"Deoxyguanosine kinase, mitochondrial",
"DGUOK",
"Deoxyguanosine Kinase Deficiency"
] | Deoxyguanosine Kinase Deficiency | Ayman W El-Hattab, Fernando Scaglia | Summary The two forms of deoxyguanosine kinase (DGUOK) deficiency are a neonatal multisystem disorder and an isolated hepatic disorder that presents later in infancy or childhood. The majority of affected individuals have the multisystem illness with hepatic disease (jaundice, cholestasis, hepatomegaly, and elevated tr... | ## Diagnosis
Deoxyguanosine kinase (DGUOK) deficiency (
Liver disease. Jaundice, cholestasis, and hepatomegaly, progressing to liver failure
Neurologic manifestations. Hypotonia, nystagmus, and developmental delay
Lactic acidosis and hypoglycemia
Elevated transaminases alanine aminotransferase and aspartate amin... | [] | 18/6/2009 | 9/2/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
diamond-b | diamond-b | [
"Diamond-Blackfan Anemia (DBA)",
"Diamond-Blackfan Syndrome (DBS)",
"Diamond-Blackfan Anemia (DBA)",
"Diamond-Blackfan Syndrome (DBS)",
"Erythroid transcription factor",
"HEAT repeat-containing protein 3",
"Large ribosomal subunit protein eL15",
"Large ribosomal subunit protein eL18",
"Large ribosom... | DBA Syndrome | Colin Sieff | Summary DBA syndrome is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50% of affected individuals, and growth deficiency in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals dur... | ## Diagnosis
DBA syndrome
Pallor, weakness, poor weight gain
Growth deficiency (observed in 30%)
Congenital malformations (observed in ~30%-50%); in particular craniofacial, upper-limb (thumb), heart, and genitourinary malformations
Macrocytic anemia with no other significant cytopenias
Increased erythrocyte ... | [] | 25/6/2009 | 31/7/2025 | 23/3/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
diastrophic-d | diastrophic-d | [
"Diastrophic Dwarfism, SLC26A2-Related Diastrophic Dysplasia",
"Diastrophic Dwarfism",
"SLC26A2-Related Diastrophic Dysplasia",
"Sulfate transporter",
"SLC26A2",
"Diastrophic Dysplasia"
] | Diastrophic Dysplasia | Sheila Unger, Andrea Superti-Furga | Summary Diastrophic dysplasia (DTD) is characterized by limb shortening, normal-sized head, hitchhiker thumbs, spinal deformities (scoliosis, exaggerated lumbar lordosis, cervical kyphosis), and contractures of the large joints with deformities and early-onset osteoarthritis. Other typical findings are ulnar deviation ... | ## Diagnosis
No consensus clinical diagnostic criteria for diastrophic dysplasia (DTD) have been published. However, cystic ear swelling, if present, is pathognomonic.
DTD
Limb shortening
Normal-sized head
Slight trunk shortening
Hitchhiker thumbs (
Symphalangism with missing interphalangeal creases
Small che... | [] | 15/11/2004 | 23/12/2021 | 16/3/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dkc | dkc | [
"Zinsser-Cole-Engman Syndrome",
"Zinsser-Cole-Engman Syndrome",
"Revesz Syndrome",
"Classic Dyskeratosis Congenita",
"Hoyeraal Hreidarsson Syndrome",
"Coats Plus Syndrome",
"Adrenocortical dysplasia protein homolog",
"CST complex subunit CTC1",
"CST complex subunit STN1",
"H/ACA ribonucleoprotein ... | Dyskeratosis Congenita and Related Telomere Biology Disorders | Sharon A Savage, Marena R Niewisch | Summary Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with ve... | Classic dyskeratosis congenita
Hoyeraal Hreidarsson syndrome
Revesz syndrome
Coats plus syndrome
• Classic dyskeratosis congenita
• Hoyeraal Hreidarsson syndrome
• Revesz syndrome
• Coats plus syndrome
## Diagnosis
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired te... | [
"BP Alter, N Giri, SA Savage, PS Rosenberg. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.. Haematologica. 2018;103:30-9",
"BP Alter, PS Rosenberg, N Giri, GM Baerlocher, PM Lansdorp, SA Savage. Telomere length is associated with disease sev... | 12/11/2009 | 31/3/2022 | 19/1/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dld-def | dld-def | [
"DLD Deficiency",
"E3 Deficiency",
"DLD Deficiency",
"E3 Deficiency",
"Dihydrolipoyl dehydrogenase, mitochondrial",
"DLD",
"Dihydrolipoamide Dehydrogenase Deficiency"
] | Dihydrolipoamide Dehydrogenase Deficiency | Shane C Quinonez, Jess G Thoene | Summary The phenotypes of dihydrolipoamide dehydrogenase (DLD) deficiency are an overlapping continuum that ranges from early-onset neurologic manifestations to adult-onset liver involvement and, rarely, a myopathic presentation. Early-onset DLD deficiency typically manifests in infancy as hypotonia with lactic acidosi... | ## Diagnosis
Dihydrolipoamide dehydrogenase (DLD) functions as the E3 subunit of three mitochondrial enzyme complexes: branched-chain alpha-ketoacid dehydrogenase (BCKDH) complex, α-ketoglutarate dehydrogenase (αKGDH) complex, and pyruvate dehydrogenase (PDH) complex [
The phenotypic spectrum of DLD deficiency includ... | [
"N Ajit Bolar, AV Vanlander, C Wilbrecht, N Van der Aa, J Smet, B De Paepe, G Vandeweyer, F Kooy, F Eyskens, E De Latter, G Delanghe, P Govaert, JG Leroy, B Loeys, R Lill, L Van Laer, R Van Coster. Mutation of the iron-sulfur cluster assembly gene IBA57 causes severe myopathy and encephalopathy.. Hum Mol Genet. 201... | 17/7/2014 | 9/7/2020 | 30/9/2021 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dlg4-synap | dlg4-synap | [
"Disks large homolog 4",
"DLG4",
"DLG4-Related Synaptopathy"
] | Zeynep Tümer, Thomas J Dye, Carlos Prada, Alexandre M White-Brown, Alex MacKenzie, Amanda M Levy | Summary The diagnosis of | ## Diagnosis
No consensus clinical diagnostic criteria for
Mild-to-severe developmental delay (DD) or intellectual disability (ID)
AND
Any of the following features presenting in infancy or childhood:
Generalized hypotonia
Developmental regression
Movement disorder, including stereotypies, ataxia, dystonia, an... | [] | 22/6/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
dmn | dmn | [
"ATP-binding cassette sub-family C member 8",
"ATP-sensitive inward rectifier potassium channel 11",
"DNA-binding protein RFX6",
"Eukaryotic translation initiation factor 2-alpha kinase 3",
"Hepatocyte nuclear factor 1-beta",
"Hexokinase-4",
"Homeobox protein Nkx-2.2",
"Insulin",
"Motor neuron and p... | Permanent Neonatal Diabetes Mellitus | Diva D De León, Sara E Pinney | Summary Permanent neonatal diabetes mellitus (PNDM) is characterized by the onset of hyperglycemia within the first six months of life (mean age: 7 weeks; range: birth to age 26 weeks). The diabetes mellitus is associated with partial or complete insulin deficiency. Clinical manifestations at the time of diagnosis incl... | ## Diagnosis
Permanent neonatal diabetes mellitus (PNDM)
Persistent hyperglycemia (plasma glucose concentration >250mg/dL) in infants younger than age six months that lasts for longer than seven to ten days [
Features typical of diabetes mellitus (e.g., glucosuria, ketonuria, hyperketonemia)
Low or undetectable p... | [] | 8/2/2008 | 14/11/2024 | 4/3/2008 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dmtn | dmtn | [
"6q24-TNDM",
"6q24-TNDM",
"Not applicable",
"Zinc finger protein 57 homolog",
"Zinc finger protein PLAGL1",
"HYMAI",
"PLAGL1",
"ZFP57",
"Diabetes Mellitus, 6q24-Related Transient Neonatal"
] | Diabetes Mellitus, 6q24-Related Transient Neonatal | Isabel Karen Temple, Deborah JG Mackay | Summary 6q24-related transient neonatal diabetes mellitus (6q24-TNDM) is defined as transient neonatal diabetes mellitus caused by genetic aberrations of the imprinted locus at 6q24. The cardinal features are: severe intrauterine growth restriction, hyperglycemia that begins in the neonatal period in a term infant and ... | ## Diagnosis
Diagnosis of 6q24-related transient neonatal diabetes mellitus (6q24-TNDM)
Severe intrauterine growth restriction
Diabetes mellitus that commences in the first six weeks of life in a term infant and resolves by age 18 months. Presentation includes the following:
Hyperglycemia
Dehydration
Plasma insul... | [
"T Arima, T Kamikihara, T Hayashida, K Kato, T Inoue, Y Shirayoshi, M Oshimura, H Soejima, T Mukai, N Wake. ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome.. Nucleic Acids Res 2005;33:2650-60",
"EI Arthur, J Zlotogora, I Lerer, J Dagan... | 10/10/2005 | 13/9/2018 | 23/12/2010 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dnajc6-pd | dnajc6-pd | [
"PARK-DNAJC6",
"PARK-DNAJC6",
"DNAJC6 Juvenile Parkinson Disease",
"DNAJC6 Type of Early-Onset Parkinson Disease",
"Auxilin",
"DNAJC6",
"DNAJC6 Parkinson Disease"
] | Manju A Kurian, Lucia Abela | Summary The majority of individuals have juvenile onset and develop symptoms before age 21 years. Developmental delay, intellectual disability, seizures, other movement disorders (e.g., dystonia, spasticity, myoclonus), and neuropsychiatric features occur in the majority of individuals with juvenile onset and often pre... | For synonyms and outdated names, see
For other genetic causes of these phenotypes, see
## Diagnosis
Onset of parkinsonism (bradykinesia, resting tremor, rigidity, postural instability) usually at the end of the first or beginning of the second decade
Rapid disease progression and neurologic regression after onset o... | [] | 13/5/2021 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
dnmt1-ddsn | dnmt1-ddsn | [
"Hereditary Sensory and Autonomic Neuropathy Type 1E (HSAN1E)",
"Autosomal Dominant Cerebellar Ataxia, Deafness, and Narcolepsy (ADCA-DN)",
"DNA (cytosine-5)-methyltransferase 1",
"DNMT1",
"DNMT1-Related Disorder"
] | Christopher J Klein | Summary The diagnosis of Each child of an individual with | Hereditary sensory and autonomic neuropathy type 1E (HSAN1E)
Autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCA-DN)
For synonyms and outdated names see
For other genetic causes of these phenotypes see
• Hereditary sensory and autonomic neuropathy type 1E (HSAN1E)
• Autosomal dominant cerebellar a... | [
"J Baets, X Duan, Y Wu, G Smith, WW Seeley, I Mademan, NM McGrath, NC Beadell, J Khoury, MV Botuyan, G Mer, GA Worrell, K Hojo, J DeLeon, M Laura, YT Liu, J Senderek, J Weis, P Van den Bergh, SL Merrill, MM Reilly, H Houlden, M Grossman, SS Scherer, P De Jonghe, PJ Dyck, CJ Klein. Defects of mutant DNMT1 are linked... | 16/2/2012 | 31/1/2019 | 17/5/2012 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
donnai | donnai | [
"DBS/FOAR Syndrome",
"Faciooculoacousticorenal Syndrome",
"FOAR Syndrome",
"FOAR Syndrome",
"DBS/FOAR Syndrome",
"Low-density lipoprotein receptor-related protein 2",
"LRP2",
"Donnai-Barrow Syndrome"
] | Donnai-Barrow Syndrome | Mauro Longoni, Sibel Kantarci, Dian Donnai, Barbara R Pober | Summary Donnai-Barrow syndrome (DBS) is characterized by typical craniofacial features (large anterior fontanelle, wide metopic suture, widow's peak, markedly widely spaced eyes, enlarged globes, downslanted palpebral fissures, posteriorly rotated ears, depressed nasal bridge, and short nose. Ocular complications inclu... | ## Diagnosis
Donnai-Barrow syndrome (DBS)
Large anterior fontanelle in infants and young children
Wide metopic suture in infants and young children
Widow's peak
Widely spaced eyes, typically marked
Enlarged globes leading to the appearance of prominent eyes
Downslanted palpebral fissures
Posteriorly rotated e... | [] | 28/8/2008 | 21/11/2018 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
drd | drd | [
"Autosomal Dominant Dopa-Responsive Dystonia",
"Autosomal Dominant Segawa Syndrome",
"DYT5a",
"Hereditary Progressive Dystonia with Marked Diurnal Fluctuation",
"Hereditary Progressive Dystonia with Marked Diurnal Fluctuation",
"Autosomal Dominant Segawa Syndrome",
"Autosomal Dominant Dopa-Responsive Dy... | GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia | Yoshiaki Furukawa | Summary GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa. This disorder typically presents with gait disturbance caused by foot dystonia, later development of ... | ## Diagnosis
GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD)
Onset typically in childhood following normal early motor development
Onset of dystonia in a limb, typically foot dystonia (equinovarus posture) resulting in gait disturbance
Later development of parkinsonism (tremor is main... | [
"E Antelmi, M Stamelou, R Liguori, KP Bhatia. Nonmotor symptoms in dopa-responsive dystonia.. Mov Disord Clin Pract. 2015;2:347-56",
"L Arrabal, L Teresa, R Sánchez-Alcudia, M Castro, C Medrano, L Gutiérrez-Solana, S Roldán, A Ormazábal, C Pérez-Cerdá, B Merinero, B Pérez, R Artuch, M Ugarte, LR Desviat. Genotype... | 21/2/2002 | 24/1/2019 | 3/5/2012 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
drpla | drpla | [
"Dentatorubral-Pallidoluysian Atrophy",
"Dentatorubral-Pallidoluysian Atrophy",
"Atrophin-1",
"ATN1",
"DRPLA"
] | DRPLA | Silvia Prades, Claudio Melo de Gusmao, Silvia Grimaldi, Yael Shiloh-Malawsky, Thomas Felton, Henry Houlden | Summary DRPLA (dentatorubral-pallidoluysian atrophy) is a progressive neurologic disorder characterized by five cardinal features (irrespective of the age of onset): ataxia, cognitive decline, myoclonus, chorea, epilepsy, and psychiatric manifestations. Onset ranges from infancy to late adulthood (range: age 0-72 years... | ## Diagnosis
No consensus clinical diagnostic criteria for DRPLA (dentatorubral-pallidoluysian atrophy) have been published.
DRPLA
The diagnosis of DRPLA
Note: Pathogenic CAG repeat expansions in
Molecular Genetic Testing Used in DRPLA
See
See
Note: To date, standard sequence-based multigene panels and exome ... | [] | 6/8/1999 | 21/9/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
drrs | drrs | [
"Duane-Radial Ray Syndrome (DRRS) / Okihiro Syndrome",
"Acro-Renal-Ocular Syndrome (AROS)",
"SALL4-Related Holt-Oram Syndrome (HOS)",
"Sal-like protein 4",
"SALL4",
"SALL4-Related Disorders"
] | Jürgen Kohlhase | Summary DRRS is characterized by uni- or bilateral Duane anomaly and radial ray malformation that can include thenar hypoplasia and/or hypoplasia or aplasia of the thumbs, hypoplasia or aplasia of the radii, shortening and radial deviation of the forearms, triphalangeal thumbs, and duplication of the thumb (preaxial po... | Duane-radial ray syndrome (DRRS) / Okihiro syndrome
Acro-renal-ocular syndrome (AROS)
For synonyms and outdated names see
• Duane-radial ray syndrome (DRRS) / Okihiro syndrome
• Acro-renal-ocular syndrome (AROS)
## Diagnosis
Radial ray malformations
Renal abnormalities: mild malrotation, ectopia, horseshoe kid... | [
"R Al-Baradie, K Yamada, C St Hilaire, WM Chan, C Andrews, N McIntosh, M Nakano, EJ Martonyi, WR Raymond, S Okumura, MM Okihiro, EC Engle. Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family.. Am J Hum Genet 2002;71:1195-9",
"W Borozdin, D... | 16/8/2004 | 17/3/2022 | 12/3/2008 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
duane | duane | [
"Duane Anomaly, Isolated",
"Duane Retraction Syndrome",
"Stilling-Turk-Duane Syndrome",
"Duane Retraction Syndrome",
"Stilling-Turk-Duane Syndrome",
"Duane Anomaly, Isolated",
"N-chimaerin",
"Sal-like protein 4",
"Transcription factor MafB",
"CHN1",
"MAFB",
"SALL4",
"Duane Syndrome"
] | Duane Syndrome | Brenda J Barry, Mary C Whitman, David G Hunter, Elizabeth C Engle | Summary Duane syndrome is a strabismus condition clinically characterized by congenital non-progressive limited horizontal eye movement accompanied by globe retraction which results in narrowing of the palpebral fissure. The lateral movement anomaly results from failure of the abducens nucleus and nerve (cranial nerve ... | ## Diagnosis
Duane syndrome is a strabismus condition clinically characterized by congenital non-progressive limited horizontal eye movement accompanied by globe retraction which results in narrowing of the palpebral fissure. The diagnosis of Duane syndrome is based on clinical findings and classified into three types... | [] | 25/5/2007 | 29/8/2019 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
duarte-gal | duarte-gal | [
"Duarte Galactosemia",
"Duarte Galactosemia",
"Galactose-1-phosphate uridylyltransferase",
"GALT",
"Duarte Variant Galactosemia"
] | Duarte Variant Galactosemia | Judith L Fridovich-Keil, Michael J Gambello, Rani H Singh, J Daniel Sharer | Summary Infants with Duarte variant galactosemia who receive breast milk or a high galactose-containing formula (dairy milk-based formula) are typically asymptomatic and show the same prevalence of acute issues seen in the general newborn population. For decades it has been unclear whether Duarte variant galactosemia r... | ## Diagnosis
Duarte variant galactosemia is defined by a combination of the following:
One
Erythrocyte galactose-1-phosphate uridylyltransferase (GALT) enzyme activity that is typically about 25% of control activity
Duarte variant galactosemia, caused by a partial deficiency in erythrocyte galactose-1-phosphate uri... | [] | 4/12/2014 | 23/5/2019 | 25/6/2020 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dup15q | dup15q | [
"Maternal Interstitial 15q11.2-q13.1 Duplication or Triplication",
"Maternal Isodicentric 15q11.2-q13.1 Supernumerary Chromosome [idic(15)]",
"Not applicable",
"Not applicable",
"Maternal 15q Duplication Syndrome"
] | Maternal 15q Duplication Syndrome | Laina Lusk, Vanessa Vogel-Farley, Charlotte DiStefano, Shafali Jeste | Summary Maternal 15q duplication syndrome (maternal dup15q) is characterized by hypotonia and motor delays, intellectual disability, autism spectrum disorder (ASD), and epilepsy including infantile spasms. Rarely, maternal dup15q may also be associated with psychosis or sudden unexplained death. Those with a maternal i... | Maternal isodicentric 15q11.2-q13.1 supernumerary chromosome [idic(15)] resulting in tetrasomy or hexasomy for 15q11.2-q13.1
Maternal interstitial 15q11.2-q13.1 duplication or triplication
For synonyms and outdated terms see
• Maternal isodicentric 15q11.2-q13.1 supernumerary chromosome [idic(15)] resulting in tetra... | [] | 16/6/2016 | 15/7/2021 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dup17q12 | dup17q12 | [
"Not applicable",
"Not applicable",
"17q12 Recurrent Duplication"
] | 17q12 Recurrent Duplication | Heather Mefford | Summary The 17q12 recurrent duplication is characterized by intellectual abilities ranging from normal to severe disability and other variable clinical manifestations. Speech delay is common, and most affected individuals have some degree of hypotonia and gross motor delay. Behavioral and psychiatric conditions reporte... | ## Diagnosis
The 17q12 recurrent duplication
Intellectual disability
Developmental delays
Seizures
Ocular anomalies and/or vision problems
Cardiac malformations
Renal malformations
Gastrointestinal abnormalities (e.g., duodenal obstruction)
The diagnosis of the 17q12 recurrent duplication
For this
Note: The ... | [] | 25/2/2016 | 29/4/2021 | 13/1/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
dup7q11_23 | dup7q11_23 | [
"Not applicable",
"Not applicable",
"7q11.23 Duplication Syndrome"
] | 7q11.23 Duplication Syndrome | Carolyn B Mervis, Colleen A Morris, Bonita P Klein-Tasman, Shelley L Velleman, Lucy R Osborne | Summary 7q11.23 duplication syndrome is characterized by delayed motor, speech, and social skills in early childhood; neurologic abnormalities (hypotonia, adventitious movements, and abnormal gait and station); speech sound disorders including motor speech disorders (childhood apraxia of speech and/or dysarthria) and p... | ## Diagnosis
7q11.23 duplication syndrome
Motor. Hypotonia, adventitious movements, abnormalities of gait and station, developmental coordination disorder in children
Language. Speech delay, childhood apraxia of speech, dysarthria. Expressive language is usually more delayed than receptive language.
Cognitive. Abou... | [] | 25/11/2015 | 25/3/2021 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dupl22q11 | dupl22q11 | [
"22q11.2 Microduplication Syndrome",
"Microduplication 22q11.2",
"Not applicable",
"Not applicable",
"22q11.2 Duplication"
] | 22q11.2 Duplication – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | Helen V Firth | Summary 22q11.2 duplication is defined for this The phenotype is not sufficiently distinct to be specifically suspected on clinical grounds alone. 22q11.2 duplication is not detectable by routine G-banded karyotyping. Most individuals with 22q11.2 duplication are identified by a chromosomal microarray. 22q11.2 duplica... | ## Diagnosis
22q11.2 duplication is a recently described condition, with the first report appearing in 2003 [
Because chromosomal microarray testing is commonly performed as part of the evaluation of developmental delay or intellectual disability, this significant ascertainment bias makes the phenotype associated wit... | [
"A Alberti, C Romano, M Falco, F Calì, P Schinocca, O Galesi, A Spalletta, D Di Benedetto, M. Fichera. 1.5 Mb de novo 22q11.21 microduplication in a patient with cognitive deficits and dysmorphic facial features.. Clin Genet. 2007;71:177-82",
"W Courtens, I Schramme, A. Laridon. Microduplication 22q11.2: a benign... | 17/2/2009 | 21/11/2013 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dync1h1-dis | dync1h1-dis | [
"DYNC1H1-Related Neuromuscular Disorder (DYNC1H1-NMD)",
"DYNC1H1-Related Neurodevelopmental Disorder (DYNC1H1-NDD)",
"Cytoplasmic dynein 1 heavy chain 1",
"DYNC1H1",
"DYNC1H1-Related Disorders"
] | Birk Möller, Antonietta Coppola, Heinz Jungbluth, Hormos Salimi Dafsari | Summary The diagnosis of a | Motor axonal neuropathy
± delayed motor milestones
Developmental delay / intellectual disability
Epilepsy
Neurobehavioral/psychiatric manifestations
Movement disorders
± malformations of cortical development
CNS = central nervous system; PNS = peripheral nervous system
Based on
• Motor axonal neuropathy
• ± d... | [] | 21/3/2024 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
dyrk1a-id | dyrk1a-id | [
"Dual specificity tyrosine-phosphorylation-regulated kinase 1A",
"DYRK1A",
"DYRK1A Syndrome"
] | Bregje WM van Bon, Bradley P Coe, Bert BA de Vries, Evan E Eichler | Summary The diagnosis of | ## Diagnosis
Intrauterine growth retardation
Microcephaly
Typical facial gestalt:
During infancy and childhood facial features include prominent ears, deep-set eyes, mild upslanted palpebral fissures, a short nose with a broad nasal tip, and retrognathia with a broad chin.
In adulthood, the nasal bridge may become... | [
"ATM Blackburn, N Bekheirnia, VC Uma, ME Corkins, Y Xu, JA Rosenfeld, MN Bainbridge, Y Yang, P Liu, S Madan-Khetarpal, MR Delgado, L Hudgins, I Krantz, D Rodriguez-Buritica, PG Wheeler, L Al-Gazali, A Mohamed Saeed Mohamed Al Shamsi, N Gomez-Ospina, HT Chao, GM Mirzaa, AE Scheuerle, MK Kukolich, F Scaglia, C Eng, H... | 17/12/2015 | 18/3/2021 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
dystonia-ov | dystonia-ov | [
"85/88 kDa calcium-independent phospholipase A2",
"Arylsulfatase A",
"Atrophin-1",
"Battenin",
"Beta-galactosidase",
"Biotinidase",
"Bis(monoacylglycero)phosphate synthase CLN5",
"BTB/POZ domain-containing protein KCTD7",
"Calcium/manganese antiporter SLC30A10",
"Cathepsin D",
"Cathepsin F",
"... | Hereditary Dystonia Overview | Christine Klein, Katja Lohmann, Connie Marras, Alexander Münchau | Summary The purpose of this overview is to: Describe the Review the Provide an Review the Provide information regarding | ## Clinical Characteristics of Dystonia
Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive movements and/or postures. Dystonic movements are typically patterned and twisting, and may be associated with tremor. Dystonia is often initiated or... | [] | 28/10/2003 | 22/6/2017 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
dystonia | dystonia | [
"Early-Onset Torsion Dystonia",
"Oppenheim's Dystonia",
"Early-Onset Torsion Dystonia",
"Oppenheim's Dystonia",
"Torsin-1A",
"TOR1A",
"DYT1 Early-Onset Isolated Dystonia"
] | DYT1 Early-Onset Isolated Dystonia | Laurie Ozelius, Naomi Lubarr | Summary DYT1 early-onset isolated dystonia typically presents in childhood or adolescence and only on occasion in adulthood. Dystonic muscle contractions causing posturing or irregular tremor of a leg or arm are the most common presenting findings. Dystonia is usually first apparent with specific actions such as writin... | ## Diagnosis
DYT1 early-onset isolated dystonia
Isolated dystonia (defined as involuntary contraction of muscles that causes repetitive, patterned, and often twisting movements or postures) with:
No other abnormalities on neurologic examination (except tremor);
Normal routine neuroimaging;
No history of known caus... | [] | 14/4/1999 | 17/11/2016 | 23/11/2010 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
ea1 | ea1 | [
"EA1",
"EA1",
"Potassium voltage-gated channel subfamily A member 1",
"KCNA1",
"Episodic Ataxia Type 1"
] | Episodic Ataxia Type 1 | Sonia M Hasan, Maria Cristina D'Adamo | Summary Episodic ataxia type 1 (EA1) is a potassium channelopathy characterized by constant myokymia and dramatic episodes of spastic contractions of the skeletal muscles of the head, arms, and legs with loss of both motor coordination and balance. During attacks individuals may experience a number of variable symptoms... | ## Diagnosis
No consensus diagnostic criteria for episodic ataxia type 1 (EA1) have been published.
Episodic ataxia type 1 (EA1)
Episodic attacks of:
Generalized ataxia, loss of balance, and jerking movements of the head, arms, and legs
Dysarthria
Incoordination of hands
Weakness
Tremors
Muscle twitching/sti... | [
"JP Adelman, CT Bond, M Pessia, J Maylie. Episodic ataxia results from voltage-dependent potassium channels with altered functions.. Neuron 1995;15:1449-54",
"DL Browne, ST Gancher, JG Nutt, ER Brunt, EA Smith, P Kramer, M Litt. Episodic ataxia/myokymia syndrome is associated with point mutations in the human pot... | 9/2/2010 | 31/5/2018 | 1/11/2018 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
ea2 | ea2 | [
"EA2",
"Voltage-dependent P/Q-type calcium channel subunit alpha-1A",
"CACNA1A",
"Episodic Ataxia Type 2"
] | Episodic Ataxia Type 2 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | Sian Spacey | Summary Episodic ataxia type 2 (EA2) is characterized by paroxysmal attacks of ataxia, vertigo, and nausea typically lasting minutes to days in duration. Attacks can be associated with dysarthria, diplopia, tinnitus, dystonia, hemiplegia, and headache. About 50% of individuals with EA2 have migraine headaches. Onset i... | ## Diagnosis
There are no formal clinical diagnostic criteria for the diagnosis of episodic ataxia type 2.
Episodic ataxia type 2 (EA2)
Episodic attacks:
Including vertigo, gait and limb ataxia, and nystagmus lasting from five minutes to days, possibly associated with nausea and vomiting
Provoked by exercise, em... | [] | 24/2/2003 | 15/10/2015 | 30/6/2009 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
eb-pa | eb-pa | [
"EB-PA",
"EB-PA",
"Integrin alpha-6",
"Integrin beta-4",
"Plectin",
"ITGA6",
"ITGB4",
"PLEC",
"Epidermolysis Bullosa with Pyloric Atresia"
] | Epidermolysis Bullosa with Pyloric Atresia | Anne W Lucky, Emily Gorell | Summary Epidermolysis bullosa with pyloric atresia (EB-PA) is characterized by fragility of the skin and mucous membranes, manifested by blistering with little or no trauma; congenital pyloric atresia; renal and/or ureteral anomalies; and protein-losing enteropathy. The course of EB-PA is usually severe and most often ... | ## Diagnosis
Epidermolysis bullosa with pyloric atresia (EB-PA)
Fragility of the skin with:
Blistering with little or no trauma. Blistering may be mild or severe. Blisters generally heal with no significant scarring.
Significant oral and mucous membrane involvement
Large areas of absent skin (aplasia cutis congeni... | [
"M Azarian, S Dreux, E Vuillard, G Meneguzzi, S Haber, F Guimiot, F Muller. Prenatal diagnosis of inherited epidermolysis bullosa in a patient with no family history: a case report and literature review.. Prenat Diagn. 2006;26:57-9",
"RY Birnbaum, D Landau, K Elbedour, R Ofir, OS Birk, R Carmi. Deletion of the fi... | 22/2/2008 | 26/1/2023 | 28/4/2009 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
ebd | ebd | [
"DEB",
"Epidermolysis Bullosa Dystrophica",
"Epidermolysis Bullosa Dystrophica",
"DEB",
"Dominant DEB (DDEB)",
"Compound Heterozygous DEB",
"Recessive DEB (RDEB)",
"Collagen alpha-1(VII) chain",
"COL7A1",
"Dystrophic Epidermolysis Bullosa"
] | Dystrophic Epidermolysis Bullosa | Anne W Lucky, Elena Pope, Sarah Crawford | Summary Dystrophic epidermolysis bullosa (DEB) is characterized by skin fragility manifested by blistering and erosions with minimal trauma. Many individuals also have dystrophic or absent nails. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and ... | Recessive DEB (RDEB)
Severe
Intermediate
Inversa
Localized
Pruriginosa
Self-improving
Dominant DEB (DDEB)
Intermediate
Localized
Pruriginosa
Self-improving
Compound heterozygous DEB
DEB, severe
Based on
For synonyms and outdated names see
Individuals with one
• Recessive DEB (RDEB)
• Severe
• Interme... | [] | 21/8/2006 | 27/3/2025 | 7/8/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
ebf3-ndd | ebf3-ndd | [
"Hypotonia, Ataxia, and Delayed Development Syndrome (HADDS)",
"Hypotonia, Ataxia, and Delayed Development Syndrome (HADDS)",
"Transcription factor COE3",
"EBF3",
"EBF3 Neurodevelopmental Disorder"
] | Dhanya Lakshmi Narayanan, Kerstin Kutsche, Katta M Girisha | Summary The diagnosis of | ## Diagnosis
No consensus clinical diagnostic criteria for
Microcephaly
Generalized hypotonia
Feeding difficulties
Genitourinary abnormalities such as micropenis, cryptorchidism, vesicoureteral reflux, renal anomalies
Strabismus
Speech delay, mainly expressive speech delay, dysarthria
Ataxia
High pain threshol... | [
"SJ Beecroft, M Olive, LG Quereda, P Gallano, I Ojanguren, C McLean, P McCombe, NG Laing, G Ravenscroft. Cylindrical spirals in two families: Clinical and genetic investigations.. Neuromuscul Disord. 2020;30:151-8",
"PR Blackburn, SS Barnett, MT Zimmermann, MA Cousin, C Kaiwar, E Pinto, F Vairo, Z Niu, MJ Ferber,... | 6/5/2021 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
ebj | ebj | [
"Collagen alpha-1(XVII) chain",
"Integrin beta-4",
"Laminin subunit alpha-3",
"Laminin subunit beta-3",
"Laminin subunit gamma-2",
"COL17A1",
"ITGB4",
"LAMA3",
"LAMB3",
"LAMC2",
"Junctional Epidermolysis Bullosa"
] | Junctional Epidermolysis Bullosa | Ellen G Pfendner, Anne W Lucky | Summary Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airwa... | ## Diagnosis
Junctional epidermolysis bullosa (JEB)
Blistering with little or no trauma. Blistering may be mild or severe; however, blisters generally heal with no significant scarring.
Significant oral and mucous membrane involvement
Note: Blistering may be severe and granulation tissue can form on the skin around... | [
"N Almaani, L Liu, PJ Dopping-Hepenstal, PA Lovell, JE Lai-Cheong, RM Graham, JE Mellerio, JA McGrath. Autosomal dominant junctional epidermolysis bullosa.. Br J Dermatol. 2009;160:1094-7",
"GH Ashton, P Sorelli, JE Mellerio, FM Keane, RA Eady, JA McGrath. Alpha 6 beta 4 integrin abnormalities in junctional epide... | 22/2/2008 | 20/12/2018 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
ebs | ebs | [
"Severe Epidermolysis Bullosa Simplex",
"Intermediate Epidermolysis Bullosa Simplex",
"Localized Epidermolysis Bullosa Simplex",
"Epidermolysis Bullosa Simplex with Mottled Pigmentation",
"Epidermolysis Bullosa Simplex, Intermediate with Muscular Dystrophy",
"Epidermolysis Bullosa Simplex, Intermediate wi... | Epidermolysis Bullosa Simplex | Jodi Y So, Joyce Teng | Summary Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by ... | Epidermolysis Bullosa Simplex (EBS): Included Phenotypes
Localized EBS
Intermediate EBS
Severe EBS
EBS with mottled pigmentation
EBS, intermediate with
EBS, intermediate with muscular dystrophy
EBS, severe with pyloric atresia
EBS with migratory circinate erythema
EBS, intermediate with cardiomyopathy
EBS, lo... | [
"RJ Abitbol, LH Zhou. Treatment of epidermolysis bullosa simplex, Weber-Cockayne type, with botulinum toxin type A.. Arch Dermatol 2009;145:13-5",
"A Alkhalifah, C Chiaverini, A Charlesworth, C Has, JP Lacour. Burnlike scars: a sign suggestive of KLHL24-related epidermolysis bullosa simplex.. Pediatr Dermatol 201... | 7/10/1998 | 4/8/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
eccl | eccl | [
"Fishman Syndrome",
"Haberland Syndrome",
"Fishman Syndrome",
"Haberland Syndrome",
"Fibroblast growth factor receptor 1",
"GTPase KRas",
"FGFR1",
"KRAS",
"Encephalocraniocutaneous Lipomatosis"
] | Encephalocraniocutaneous Lipomatosis | Ute Moog, William B Dobyns | Summary Encephalocraniocutaneous lipomatosis (ECCL) comprises a spectrum of predominantly congenital anomalies. In its typical form, ECCL is characterized by congenital anomalies of the skin (nevus psiloliparus, patchy or streaky non-scarring alopecia, subcutaneous lipomas in the frontotemporal region, focal skin aplas... | ## Diagnosis
Clinical diagnostic criteria for encephalocraniocutaneous lipomatosis (ECCL) have been published [
ECCL
Biopsy-proven nevus psiloliparus (NP) (
Possible NP in addition to one or more of the other minor skin criteria listed below
Two or more minor skin criteria listed
Intracranial lipoma (
Intras... | [] | 27/1/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
echs1-def | echs1-def | [
"ECHS1D",
"ECHS1 Deficiency",
"Mitochondrial Short-Chain Enoyl-CoA Hydratase Deficiency",
"SCEH Deficiency",
"ECHS1D",
"ECHS1 Deficiency",
"Mitochondrial Short-Chain Enoyl-CoA Hydratase Deficiency",
"SCEH Deficiency",
"Enoyl-CoA hydratase, mitochondrial",
"ECHS1",
"Mitochondrial Short-Chain Enoy... | Mitochondrial Short-Chain Enoyl-CoA Hydratase 1 Deficiency | Rebecca Ganetzky, Carol Stojinski | Summary Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D) represents a clinical spectrum in which several phenotypes have been described: The most common phenotype presents in the neonatal period with severe encephalopathy and lactic acidosis and later manifests Leigh-like signs and symptoms. Those wi... | ## Diagnosis
No consensus clinical diagnostic criteria for ECHS1 deficiency (ECHS1D) have been published.
Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency (ECHS1D)
Developmental delay, often severe [
Infantile encephalopathy (may be epileptic), hypotonia, and/or spasticity [
Dystonia (exercise induce... | [] | 20/6/2019 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
ed2 | ed2 | [
"Clouston Syndrome",
"Clouston Syndrome",
"Gap junction beta-6 protein",
"GJB6",
"Hidrotic Ectodermal Dysplasia 2"
] | Hidrotic Ectodermal Dysplasia 2 | Jemima Mellerio, Danielle Greenblatt | Summary Hidrotic ectodermal dysplasia 2, or Clouston syndrome (referred to as HED2 throughout this Sparse scalp hair and dysplastic nails are seen early in life. In infancy, scalp hair is fine, sparse, and brittle. Progressive hair loss may lead to total alopecia by puberty. The nails may be milky white in early childh... | ## Diagnosis
Hidrotic ectodermal dysplasia 2 (HED2, Clouston syndrome)
The molecular diagnosis of HED2
Note: (1) Per ACMG/AMP variant interpretation guidelines, the terms "pathogenic variant" and "likely pathogenic variant" are synonymous in a clinical setting, meaning that both are considered diagnostic and can be ... | [] | 25/4/2005 | 15/10/2020 | 3/4/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
edm-ad | edm-ad | [
"Cartilage oligomeric matrix protein",
"Collagen alpha-1(IX) chain",
"Collagen alpha-2(IX) chain",
"Collagen alpha-3(IX) chain",
"Matrilin-3",
"COL9A1",
"COL9A2",
"COL9A3",
"COMP",
"MATN3",
"Multiple Epiphyseal Dysplasia, Autosomal Dominant"
] | Multiple Epiphyseal Dysplasia, Autosomal Dominant | Michael D Briggs, Michael J Wright, Geert R Mortier | Summary Autosomal dominant multiple epiphyseal dysplasia (MED) presents in early childhood, usually with pain in the hips and/or knees after exercise. Affected children report fatigue with long-distance walking. Waddling gait may be present. Adult height is either in the lower range of normal or mildly shortened. The l... | ## Diagnosis
Autosomal dominant multiple epiphyseal dysplasia (MED)
Pain in the hips and/or knees and fatigue, often after exercise (frequently starting in early childhood)
Adult height in the lower range of normal or mildly shortened
Restricted range of movement at the major joints (e.g., elbows)
Early-onset os... | [] | 8/1/2003 | 4/7/2024 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
edm | edm | [
"SLC26A2-Related Recessive MED (SLC26A2-rMED)",
"SLC26A2-Related Recessive MED (SLC26A2-rMED)",
"Sulfate transporter",
"SLC26A2",
"SLC26A2-Related Multiple Epiphyseal Dysplasia"
] | Sheila Unger, Andrea Superti-Furga | Summary Diagnosis of | ## Diagnosis
Joint pain (usually in the hips and knees). Onset of pain is variable, but usually occurs in late childhood. Some individuals have no pain.
Deformity of hands, feet, and knees
Scoliosis
Flat epiphyses with early arthritis (degenerative and painful changes in the articular cartilage of the hip joint... | [] | 29/8/2002 | 19/1/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
edmd | edmd | [
"Emerin",
"Four and a half LIM domains protein 1",
"Prelamin-A/C",
"EMD",
"FHL1",
"LMNA",
"Emery-Dreifuss Muscular Dystrophy"
] | Emery-Dreifuss Muscular Dystrophy | Gisèle Bonne, France Leturcq, Rabah Ben Yaou | Summary Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement t... | ## Diagnosis
Emery-Dreifuss muscular dystrophy (EDMD)
Atrial fibrillation, flutter and standstill, supraventricular and ventricular arrhythmias, and atrio-ventricular and bundle-branch blocks may be identified on resting electrocardiography (EKG) or by 24-hour ambulatory EKG.
Dilated or hypertrophic cardiomyopathy... | [
"RJ Aldwinckle, AS Carr. The anesthetic management of a patient with Emery-Dreifuss muscular dystrophy for orthopedic surgery.. Can J Anaesth 2002;49:467-70",
"M Alsheimer, R Benavente. Change of karyoskeleton during mammalian spermatogenesis: expression pattern of nuclear lamin C2 and its regulation.. Exp Cell R... | 29/9/2004 | 15/8/2019 | 24/8/2010 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
eds-mc | eds-mc | [
"mcEDS",
"Adducted Thumb-Clubfoot Syndrome (ATCS)",
"Dündar Syndrome",
"Ehlers-Danlos Syndrome, Kosho Type (EDS-KT)",
"mcEDS",
"Adducted Thumb-Clubfoot Syndrome (ATCS)",
"Dündar Syndrome",
"Ehlers-Danlos Syndrome, Kosho Type (EDS-KT)",
"Carbohydrate sulfotransferase 14",
"Dermatan-sulfate epimeras... | Musculocontractural Ehlers-Danlos Syndrome | Tomoki Kosho, Tomomi Yamaguchi, Shuji Mizumoto, Roberto Mendoza-Londono | Summary Musculocontractural Ehlers-Danlos syndrome (mcEDS) is characterized by multiple congenital contractures, progressive foot and ankle deformities, hypermobility of the small joints, recurrent dislocations, spinal deformities, characteristic craniofacial features (large anterior fontanel with delayed closure, shor... | ## Diagnosis
No consensus clinical diagnostic criteria for musculocontractural Ehlers-Danlos syndrome (mcEDS) have been published.
Musculocontractural EDS
Multiple congenital contractures, characteristically adduction-flexion contractures and/or talipes equinovarus (clubfoot)
Characteristic craniofacial features,... | [] | 15/5/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
eds-pd | eds-pd | [
"EDS Type VIII",
"pEDS",
"pEDS",
"EDS Type VIII",
"Complement C1r subcomponent",
"Complement C1s subcomponent",
"C1R",
"C1S",
"Periodontal Ehlers-Danlos Syndrome"
] | Periodontal Ehlers-Danlos Syndrome | Ines Kapferer-Seebacher, Fleur S van Dijk, Johannes Zschocke | Summary Periodontal Ehlers-Danlos syndrome (pEDS) is characterized by distinct oral manifestations. Periodontal tissue breakdown beginning in the teens results in premature loss of teeth. Lack of attached gingiva and thin and fragile gums lead to gingival recession. Connective tissue abnormalities of pEDS typically inc... | ## Diagnosis
Formal clinical diagnostic criteria for periodontal Ehlers-Danlos syndrome (pEDS) were established in the 2017 revised Ehlers-Danlos syndrome nosology [
Periodontal Ehlers-Danlos syndrome (pEDS)
Severe periodontitis of early onset (childhood or adolescence)
Generalized lack of attached gingiva (
Pre... | [
"JM Albandar. Aggressive and acute periodontal diseases.. Periodontol 2000 2014;65:7-12",
"I Bally, F Dalonneau, A Chouquet, R Grobner, A Amberger, I Kapferer-Seebacher, H Stoiber, J Zschocke, NM Thielens, V Rossi, C Gaboriaud. Two different missense C1S mutations, associated to periodontal Ehlers-Danlos syndrome... | 29/7/2021 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
eds | eds | [
"Classical Ehlers-Danlos Syndrome",
"Ehlers-Danlos Syndrome, Classical Type",
"cEDS",
"Classical Ehlers-Danlos Syndrome",
"Ehlers-Danlos Syndrome, Classical Type",
"cEDS",
"Ehlers-Danlos Syndrome, Classic Type, COL5A1-Related",
"Ehlers-Danlos Syndrome, Classic Type, COL5A2-Related",
"Collagen alpha-... | Classic Ehlers-Danlos Syndrome | Fransiska Malfait, Sofie Symoens, Delfien Syx | Summary Classic Ehlers-Danlos syndrome (cEDS) is a heritable connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft, velvety, or doughy to the touch. In addition, the skin is hyperextensible, meaning that it extends easily and ... | ## Diagnosis
There are no consensus clinical diagnostic criteria for classic Ehlers-Danlos syndrome (cEDS); diagnosis requires molecular testing.
Classic EDS should be suspected in a proband with either of the following:
OR
Beighton Criteria for Joint Hypermobility
A total score of ≥5 is considered positive for ... | [] | 29/5/2007 | 1/2/2024 | 11/5/2010 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
eds3 | eds3 | [
"Ehlers-Danlos Syndrome Hypermobility Type",
"Ehlers-Danlos Syndrome Type III",
"hEDS",
"hEDS",
"Ehlers-Danlos Syndrome Hypermobility Type",
"Ehlers-Danlos Syndrome Type III",
"Hypermobile Ehlers-Danlos Syndrome"
] | Hypermobile Ehlers-Danlos Syndrome | Alan Hakim | Summary Hypermobile Ehlers-Danlos syndrome (hEDS) is characterized by generalized joint hypermobility, joint instability, pain, soft and hyperextensible skin with atrophic scars and easy bruising, dental crowding, abdominal hernias, pelvic organ prolapse, marfanoid body habitus, mitral valve prolapse, and aortic root d... | ## Diagnosis
The diagnostic criteria for hypermobile Ehlers-Danlos syndrome (hEDS) were revised by the International Consortium on Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders in 2017 [
Hypermobile EDS should be suspected in adult probands (individuals who have reached biologic maturity) with the foll... | [] | 22/10/2004 | 22/2/2024 | 21/6/2018 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
eds4 | eds4 | [
"EDS Type IV",
"Ehlers-Danlos Syndrome, Vascular Type",
"vEDS",
"Ehlers-Danlos Syndrome, Vascular Type",
"EDS Type IV",
"vEDS",
"Collagen alpha-1(III) chain",
"COL3A1",
"Vascular Ehlers-Danlos Syndrome"
] | Vascular Ehlers-Danlos Syndrome | Peter H Byers | Summary Vascular Ehlers-Danlos syndrome (vEDS) is characterized by arterial, intestinal, and/or uterine fragility; thin, translucent skin; easy bruising; characteristic facial appearance (thin vermilion of the lips, micrognathia, narrow nose, prominent eyes); and an aged appearance to the extremities, particularly the ... | ## Diagnosis
No consensus clinical diagnostic criteria for vascular Ehlers-Danlos syndrome (vEDS) have been published. When the diagnosis is suspected on clinical grounds, molecular diagnostic testing of
Vascular EDS
Arterial aneurysms, dissection, or rupture
Intestinal rupture, most often in the sigmoid colon
U... | [] | 2/9/1999 | 10/4/2025 | 25/1/2005 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
eds6 | eds6 | [
"Ehlers-Danlos Syndrome Type VIA (EDS VIA)",
"Lysyl-Hydroxylase 1 Deficiency",
"PLOD1-kEDS",
"Ehlers-Danlos Syndrome Type VIA (EDS VIA),",
"Lysyl-Hydroxylase 1 Deficiency",
"PLOD1-kEDS",
"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",
"PLOD1",
"PLOD1-Related Kyphoscoliotic Ehlers-Danlos Syndrom... | Marianne Rohrbach, Cecilia Giunta | Summary The diagnosis of | ## Diagnosis
Congenital muscular hypotonia
Congenital or early-onset kyphoscoliosis (progressive or nonprogressive)
Generalized joint hypermobility with dislocations/subluxations (shoulders, hips, and knees in particular)
Skin hyperextensibility
Skin fragility (easy bruising, friable skin, poor wound healing, ... | [] | 2/2/2000 | 13/6/2024 | 18/10/2018 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
ee | ee | [
"ETHE1 Deficiency",
"ETHE1 Deficiency",
"Persulfide dioxygenase ETHE1, mitochondrial",
"ETHE1",
"Ethylmalonic Encephalopathy"
] | Ethylmalonic Encephalopathy | Ivano Di Meo, Costanza Lamperti, Valeria Tiranti | Summary Ethylmalonic encephalopathy (EE) is a severe, early-onset, progressive disorder characterized by developmental delay / mild-to-severe intellectual disability; generalized infantile hypotonia that evolves into hypertonia, spasticity, and (in some instances) dystonia; generalized tonic-clonic seizures; and genera... | ## Diagnosis
Ethylmalonic encephalopathy (EE)
Global neurologic impairment
Early-onset progressive psychomotor regression
Seizures
Dystonia
Diffuse microvasculature injury
Petechiae and/or purpura
Orthostatic acrocyanosis
Hemorrhagic suffusions of mucosal surfaces
Chronic hemorrhagic diarrhea
Increased b... | [
"AB Burlina, C Dionisi-Vici, MJ Bennett, KM Gibson, S Servidei, E Bertini, DE Hale, E Schmidt-Sommerfeld, G Sabetta, F Zacchello. A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts.. J Pediatr. 1994;124:79-86",
"I Di Meo, A Auricchio, C Lamperti, A Burlina, C Viscomi, M. Zevi... | 21/9/2017 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
eed-og | eed-og | [
"Polycomb protein EED",
"EED",
"EED-Related Overgrowth"
] | Ana Sequerra Amram Cohen, William Thomas Gibson | Summary The diagnosis of | ## Diagnosis
Overgrowth manifesting as:
Tall stature (z score ≥2 for age, equivalent to standard deviation ≥2 above the mean)
Note: An adult of normal stature who had relatively tall stature and/or advanced bone age in childhood or adolescence could meet criteria for overgrowth.
Macrocephaly (z score ≥2 for age)
... | [] | 11/4/2019 | 8/5/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
efemp2-cutis-laxa | efemp2-cutis-laxa | [
"Autosomal Recessive Cutis Laxa Type 1B (ARCL1B)",
"Autosomal Recessive Cutis Laxa Type 1B (ARCL1B)",
"EGF-containing fibulin-like extracellular matrix protein 2",
"EFEMP2",
"EFEMP2-Related Cutis Laxa"
] | Bart Loeys, Anne De Paepe, Zsolt Urban | Summary The diagnosis of | ## Diagnosis
The diagnosis of
Arterial and aortic tortuosity
Aortic and arterial aneurysms. The ascending aorta and aortic arch are typically most dilated.
Aortic stenosis. The isthmus aorta in particular is often stenotic.
Stenosis and dilatation of pulmonary arteries
Pulmonary hypertension
Hemorrhagic stroke... | [
"CS Adamo, A Beyens, A Schiavinato, DR Keene, SF Tufa, M Mörgelin, J Brinckmann, T Sasaki, A Niehoff, M Dreiner, L Pottie, L Muiño-Mosquera, EY Gulec, A Gezdirici, P Braghetta, P Bonaldo, R Wagener, M Paulsson, H Bornaun, R De Rycke, M De Bruyne, F Baeke, WP Devine, B Gangaram, A Tam, M Balasubramanian, S Ellard, S... | 12/5/2011 | 22/10/2020 | 15/6/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
el-hattab-alkuraya | el-hattab-alkuraya | [
"WDR45B-Related Neurodevelopmental Disorder",
"WDR45B-Related Neurodevelopmental Disorder",
"WD repeat domain phosphoinositide-interacting protein 3",
"WDR45B",
"El-Hattab-Alkuraya Syndrome"
] | El-Hattab-Alkuraya Syndrome | Mohammed Almannai, Dana Marafi, Ayman W El-Hattab | Summary El-Hattab-Alkuraya syndrome is characterized by microcephaly (often early onset and progressive); severe-to-profound developmental delay; refractory and early-onset seizures; spastic quadriplegia with axial hypotonia; and growth deficiency with poor weight gain and short stature. Characteristic findings on brai... | ## Diagnosis
El-Hattab-Alkuraya syndrome
Progressive microcephaly
Developmental delay
Early-onset, refractory seizures
Spastic quadriplegia
Growth deficiency (poor weight gain, short stature)
Cerebral atrophy with disproportionate atrophy of the frontal lobes
Brain stem volume loss with flattening of the be... | [
"M Almannai, D Marafi, GMH Abdel-Salam, MS Zaki, R Duan, D Calame, I Herman, F Levesque, HM Elbendary, I Hegazy, WK Chung, H Kavus, K Saeidi, R Maroofian, A AlHashim, A Al-Otaibi, A Al Madhi, HM Abou Al-Seood, A Alasmari, H Houlden, JG Gleeson, JV Hunter, JE Posey, JR Lupski, AW El-Hattab. El-Hattab-Alkuraya syndro... | 29/9/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
eln-cutis-laxa | eln-cutis-laxa | [
"Autosomal Dominant Cutis Laxa Type 1 (ADCL1)",
"Autosomal Dominant Cutis Laxa Type 1 (ADCL1)",
"Elastin",
"ELN",
"ELN-Related Cutis Laxa"
] | Bert L Callewaert, Zsolt Urban | Summary The diagnosis of | ## Diagnosis
No consensus clinical diagnostic criteria for
Inguinal hernia, with increased risk at all ages
Joint hyperlaxity
Aortic root dilatation
Emphysema
Ptosis (eyelid drooping that can be caused by skin laxity)
Facial characteristics that may become more prominent with age: large ears, convex nasal ridg... | [
"L Basel-Vanagaite, O Sarig, D Hershkovitz, D Fuchs-Telem, D Rapaport, A Gat, G Isman, I Shirazi, M Shohat, CD Enk, E Birk, J Kohlhase, U Matysiak-Scholze, I Maya, C Knopf, A Peffekoven, HC Hennies, R Bergman, M Horowitz, A Ishida-Yamamoto, E Sprecher. RIN2 deficiency results in macrocephaly, alopecia, cutis laxa, ... | 29/9/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
emanuel | emanuel | [
"Supernumerary der(22)t(11;22) Syndrome",
"Supernumerary der(22)t(11;22) Syndrome",
"Emanuel Syndrome"
] | Emanuel Syndrome | Beverly S Emanuel, Elaine H Zackai, Livija Medne | Summary Emanuel syndrome is characterized by pre- and postnatal growth deficiency, microcephaly, hypotonia, severe developmental delays, ear anomalies, preauricular tags or pits, cleft or high-arched palate, congenital heart defects, kidney abnormalities, and genital abnormalities in males. The diagnosis of Emanuel syn... | ## Diagnosis
Emanuel syndrome
Severe intellectual disability
Microcephaly
Failure to thrive
Preauricular tag or pit
Ear anomalies
Cleft or high-arched palate
Micrognathia
Kidney abnormalities
Congenital heart defects
Genital abnormalities in males
The diagnosis of Emanuel syndrome
Most commonly:
47,XX,+de... | [
"MT Carter, NJ Barrowman, SA St Pierre, BS Emanuel, KM Boycott. Risk of breast cancer not increased in translocation 11;22 carriers: analysis of 80 pedigrees.. Am J Med Genet A. 2010;152A:212-4",
"M Fraccaro, J Lindsten, CE Ford, L Iselius. The 11q;22q translocation: a European collaborative analysis of 43 cases.... | 20/4/2007 | 31/8/2017 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
emc10-ndd | emc10-ndd | [
"ER membrane protein complex subunit 10",
"EMC10",
"EMC10-Related Neurodevelopmental Disorder"
] | Muhammad Umair, Majid Alfadhel | Summary The diagnosis of | ## Diagnosis
Moderate-to-severe developmental delay
Mild-to-severe intellectual disability
Behavioral abnormalities and impaired social skills
Seizures: multifocal, generalized tonic–clonic, and/or febrile
Poor weight gain and growth deficiency
Microcephaly (in some individuals)
Upper limb anomalies: cubitus v... | [
"E Haddad-Eid, N Gur, S Eid, T Pilowsky-Peleg, R Straussberg. The phenotype of homozygous EMC10 variant: a new syndrome with intellectual disability and language impairment.. Eur J Paediatr Neurol. 2022;37:56-61",
"MC Jonikas, SR Collins, V Denic, E Oh, EM Quan, V Schmid, J Weibezahn, B Schwappach, P Walter, JS W... | 15/6/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
entpd1-ndd | entpd1-ndd | [
"Autosomal Recessive Spastic Paraplegia 64",
"HSP-ENTPD1",
"Spastic Paraplegia 64 (SPG64)",
"HSP-ENTPD1",
"Spastic Paraplegia 64 (SPG64)",
"Autosomal Recessive Spastic Paraplegia 64",
"Ectonucleoside triphosphate diphosphohydrolase 1",
"ENTPD1",
"ENTPD1-Related Neurodevelopmental Disorder"
] | Daniel Calame, Isabella Herman | Summary Other neuromuscular findings can include abnormal deep tendon reflexes, weakness, neuropathy, epilepsy, dysarthria, and dysphagia. Behavior abnormalities and neurocognitive regression are common. Life span does not appear to be shortened. The diagnosis of | ## Diagnosis
Developmental delay / intellectual disability
Abnormal reflexes (hyperreflexia, hyporeflexia, and/or areflexia with gait impairment by age five years)
Behavioral concerns (attention-deficit/hyperactivity disorder, aggression, autistic features)
Neurocognitive regression not attributed to progressive ... | [
"C. Blackstone. Hereditary spastic paraplegia.. Handb Clin Neurol. 2018;148:633-52",
"DG Calame, I Herman, R Maroofian, AE Marshall, KC Donis, JM Fatih, T Mitani, H Du, CM Grochowski, SB Sousa, C Gijavanekar, S Bakhtiari, YA Ito, C Rocca, JV Hunter, VR Sutton, LT Emrick, KM Boycott, A Lossos, Y Fellig, E Prus, Y ... | 1/6/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
epb42-spherocytosis | epb42-spherocytosis | [
"Protein 4.2",
"EPB42",
"EPB42-Related Hereditary Spherocytosis"
] | Theodosia A Kalfa, Amber H Begtrup | Summary Typical laboratory findings in EPB42-HS include anemia (decreased hemoglobin [Hgb] level) and reticulocytosis (increased percentage of reticulocytes), with high mean corpuscular Hgb concentration, presence of spherocytes in the peripheral blood smear, significantly decreased or absent haptoglobin, mildly increa... | ## Diagnosis
Pallor and/or fatigue due to anemia, which is usually of mild-to-moderate severity
Jaundice
Usually intermittent and caused by unconjugated hyperbilirubinemia resulting from exacerbated hemolysis
In rare instances, caused by conjugated hyperbilirubinemia resulting from biliary obstruction
Splenomega... | [] | 13/3/2014 | 7/4/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
epg5 | epg5 | [
"Vici Syndrome",
"Ectopic P granules protein 5 homolog",
"EPG5",
"EPG5-Related Disorder"
] | Hormos Salimi Dafsari, Darius Ebrahimi-Fakhari, Afshin Saffari, Celine Deneubourg, Manolis Fanto, Heinz Jungbluth | Summary With the current widespread use of multigene panels and comprehensive genomic testing, it has become apparent that the phenotypic spectrum of The diagnosis of Of particular note, rigorous and early antibacterial and antifungal treatment (potentially in an intensive care unit setting) should be considered for ch... | With the current widespread use of multigene panels and comprehensive genomic testing based on an unbiased (i.e., not phenotype-driven) approach, it has become apparent that the phenotypic spectrum associated with biallelic
## Diagnosis
At the more severe end of the spectrum of
Thymic aplasia or hypoplasia [
Se... | [
"S Aggarwal, A Tandon, AD Bhowmik, A Dalal. Autopsy findings in EPG5-related Vici syndrome with antenatal onset: additional report of Focal cortical microdysgenesis in a second trimester fetus.. Am J Med Genet A. 2018;176:499-501",
"M Al-Owain, A Al-Hashem, M Al-Muhaizea, H Humaidan, H Al-Hindi, I Al-Homoud, I Al... | 13/10/2022 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |||
epm1 | epm1 | [
"EPM1",
"Unverricht-Lundborg Disease (ULD)",
"EPM1",
"Unverricht-Lundborg Disease (ULD)",
"Cystatin-B",
"CSTB",
"Progressive Myoclonic Epilepsy Type 1"
] | Progressive Myoclonic Epilepsy Type 1 | Anna-Elina Lehesjoki, Reetta Kälviäinen | Summary Progressive myoclonic epilepsy type 1(EPM1) is a neurodegenerative disorder characterized by onset from age six to 15 years, stimulus-sensitive myoclonus, and tonic-clonic epileptic seizures. Some years after the onset, ataxia, incoordination, intentional tremor, and dysarthria develop. Individuals with EPM1 ar... | ## Diagnosis
The diagnosis of progressive myoclonic epilepsy type 1 (EPM1)
Involuntary, action-activated myoclonic jerks AND/OR generalized tonic-clonic seizures
Photosensitive, generalized spike-and-wave and polyspike-and-wave paroxysms on EEG
Abnormal EEG (always abnormal, even before the onset of manifestations)... | [
"G Assenza, A Benvenga, E Gennaro, M Tombini, C Campana, F Assenza, G Di Pino, V. Di Lazzaro. A novel c132-134del mutation in Unverricht-Lundborg disease and the review of literature of heterozygous compound patients.. Epilepsia. 2017;58:e31-5",
"A Buzzi, M Chikhladze, C Falcicchia, B Paradiso, G Lanza, M Soukupo... | 24/6/2004 | 2/7/2020 | 18/9/2007 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
epp-ar | epp-ar | [
"Ferrochelatase, mitochondrial",
"FECH",
"Erythropoietic Protoporphyria, Autosomal Recessive"
] | Erythropoietic Protoporphyria, Autosomal Recessive | Manisha Balwani, Joseph Bloomer, Robert Desnick | Summary Erythropoietic protoporphyria (EPP) is characterized by cutaneous photosensitivity (usually beginning in infancy or childhood) that results in tingling, burning, pain, and itching within 30 minutes after exposure to sun or ultraviolet light and may be accompanied by swelling and redness. Symptoms (which may see... | ## Diagnosis
Erythropoietic protoporphyria (EPP)
Cutaneous photosensitivity, usually beginning in childhood
Burning, tingling, and itching (the most common findings); may occur within minutes of sun/light exposure, followed later by erythema and swelling
Burning, itching, and intense pain; may occur without obvio... | [
"C Aplin, SD Whatley, P Thompson, T Hoy, P Fisher, C Singer, CR Lovell, GH Elder. Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells.. J Invest Dermatol 2001;117:1647-9",
"M Balwani, D Doheny, DF Bishop, I Nazarenko, M Yasuda, HA Dailey, KE Anderson, DM Bissell, J Bloomer, ... | 27/9/2012 | 7/9/2017 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
epp-xl | epp-xl | [
"5-aminolevulinate synthase, erythroid-specific, mitochondrial",
"ALAS2",
"X-Linked Protoporphyria"
] | X-Linked Protoporphyria | Manisha Balwani, Robert Desnick | Summary X-linked protoporphyria (XLP) is characterized in affected males by cutaneous photosensitivity (usually beginning in infancy or childhood) that results in tingling, burning, pain, and itching within minutes of sun/light exposure and may be accompanied by swelling and redness. Blistering lesions are uncommon. Pa... | ## Diagnosis
There are no established guidelines or diagnostic algorithms.
X-linked protoporphyria (XLP) should be suspected in individuals with the following clinical findings and initial laboratory findings.
Cutaneous photosensitivity, usually beginning in childhood
Burning, tingling, pain, and itching of the s... | [
"C Aplin, SD Whatley, P Thompson, T Hoy, P Fisher, C Singer, CR Lovell, GH Elder. Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells.. J Invest Dermatol. 2001;117:1647-9",
"M Balwani, D Doheny, DF Bishop, I Nazarenko, M Yasuda, HA Dailey, KE Anderson, DM Bissell, J Bloomer,... | 14/2/2013 | 27/11/2019 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
etha | etha | [
"SCN9A Erythromelalgia (SCN9A-EM)",
"SCN9A Paroxysmal Extreme Pain Disorder (SCN9A-PEPD)",
"SCN9A Small Fiber Neuropathy (SCN9A-SFN)",
"Sodium channel protein type 9 subunit alpha",
"SCN9A",
"SCN9A Neuropathic Pain Syndromes"
] | Fuki M Hisama, Sulayman D Dib-Hajj, Stephen G Waxman | Summary The diagnosis of | For synonyms and outdated names see
For other genetic causes of these phenotypes, see
## Diagnosis
An
Recurrent episodes of bilateral intense, burning pain;
Redness, warmth, and occasionally swelling of the distal extremities;
Feet more commonly affected than the hands; although in severely affected individuals, ... | [
"JS Choi, X Cheng, E Foster, A Leffler, L Tyrrell, RH Te Morsche, EM Eastman, HJ Jansen, K Huehne, C Nau, SD Dib-Hajj, JP Drenth, SG Waxman. Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia.. Brain. 2010;133:1823-35",
"JS Choi, L Zhang, SD Dib-Hajj, C Han, L Tyrrell... | 6/5/2006 | 23/1/2020 | 25/9/2008 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | |
etv6-tpl | etv6-tpl | [
"ETV6-Linked Leukemia / Familial Thrombocytopenia Syndrome",
"Thrombocytopenia 5 (THC5)",
"ETV6-Linked Leukemia/Familial Thrombocytopenia Syndrome",
"Thrombocytopenia 5 (THC5)",
"Transcription factor ETV6",
"ETV6",
"ETV6-Related Thrombocytopenia and Predisposition to Leukemia"
] | Bojana Pencheva, Jorge Di Paola, Christopher C Porter | Summary Individuals with The diagnosis of | ## Diagnosis
Absent-to-moderate bleeding tendencies (e.g., menorrhagia, epistaxis, easy bruising, gum bleeding)
Hematologic malignancies, including:
B-cell acute lymphoblastic leukemia (B-ALL), which is the most common
Acute myeloid leukemia (AML)
Myelodysplastic syndrome (MDS)
Myeloproliferative neoplasms (MPN... | [] | 19/11/2020 | 26/6/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
evc | evc | [
"Chondroectodermal Dysplasia (Ellis-van Creveld)",
"Chondroectodermal Dysplasia (Ellis-van Creveld)",
"cAMP-dependent protein kinase catalytic subunit alpha",
"cAMP-dependent protein kinase catalytic subunit beta",
"Cytoplasmic dynein 2 heavy chain 1",
"Cytoplasmic dynein 2 light intermediate chain 1",
... | Ellis-van Creveld Syndrome | Jorge Diogo Da Silva, Nataliya Tkachenko, Ana Rita Soares | Summary Ellis-van Creveld (EVC) syndrome is characterized by postaxial polydactyly of the hands, disproportionate short stature with short limbs, dystrophic and/or hypoplastic nails, dental and oral manifestations, congenital heart disease, and radiologic abnormalities (narrow chest, short ribs, short tubular bones, bu... | ## Diagnosis
No consensus clinical diagnostic criteria for Ellis-van Creveld (EVC) syndrome have been published.
EVC syndrome
Bilateral postaxial polydactyly of the hands (see
Limb shortening (prenatal or postnatal)
Disproportionate short stature (prenatal or postnatal onset)
Dystrophic and/or hypoplastic nails... | [] | 26/10/2023 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
exoc6b-semd | exoc6b-semd | [
"Spondyloepimetaphyseal Dysplasia with Joint Laxity, Type 3 (SEMDJL3)",
"Spondyloepimetaphyseal Dysplasia with Joint Laxity, Type 3 (SEMDJL3)",
"Exocyst complex component 6B",
"EXOC6B",
"EXOC6B-Related Spondyloepimetaphyseal Dysplasia with Joint Laxity"
] | Gandham SriLakshmi Bhavani, Swati Singh, Katta Mohan Girisha | Summary The diagnosis of | ## Diagnosis
Congenital dislocations of the hips and knees; may also affect elbows, wrists, and/or ankles
Joint laxity affecting all joints and most evident at the wrists and fingers
Postnatal-onset short stature
Slender fingers (leptodactyly)
Genu valgum
Pes planus
Delayed carpal/tarsal bone ossification
S... | [] | 25/5/2023 | 17/7/2025 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
exosc3-pc-hypo-p | exosc3-pc-hypo-p | [
"Pontocerebellar Hypoplasia Type 1B (PCH1B)",
"Pontocerebellar Hypoplasia Type 1B (PCH1B)",
"Exosome complex component RRP40",
"EXOSC3",
"EXOSC3 Pontocerebellar Hypoplasia"
] | Frank Baas, Tessa van Dijk | Summary The diagnosis of | ## Diagnosis
Diagnosis of
Hypotonia (onset is usually at birth, but a later onset is possible)
Signs of neurogenic muscle atrophy, such as muscle atrophy and decreased tendon reflexes
Central motor neuron signs (spasticity, dystonia), especially in individuals with prolonged survival
Lower motor neuron involveme... | [
"R Biancheri, D Cassandrini, F Pinto, R Trovato, M Di Rocco, M Mirabelli-Badenier, M Pedemonte, C Panicucci, H Trucks, T Sander, F Zara, A Rossi, P Striano, C Minetti, FM Santorelli. EXOSC3 mutations in isolated cerebellar hypoplasia and spinal anterior horn involvement.. J Neurol. 2013;260:1866-70",
"AP Di Giova... | 21/8/2014 | 24/9/2020 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] | ||
ext | ext | [
"Diaphyseal Aclasis",
"Hereditary Multiple Exostoses",
"Multiple Cartilaginous Exostoses",
"Multiple Cartilaginous Exostoses",
"Diaphyseal Aclasis",
"Hereditary Multiple Exostoses",
"Exostosin-1",
"Exostosin-2",
"EXT1",
"EXT2",
"Hereditary Multiple Osteochondromas"
] | Hereditary Multiple Osteochondromas | Wim Wuyts, Gregory A Schmale, Howard A Chansky, Wendy H Raskind | Summary Hereditary multiple osteochondromas (HMO), previously called hereditary multiple exostoses (HME), is characterized by growths of multiple osteochondromas, benign cartilage-capped bone tumors that grow outward from the metaphyses of long bones. Osteochondromas can be associated with a reduction in skeletal growt... | ## Diagnosis
No consensus clinical diagnostic criteria for hereditary multiple osteochondromas (HMO) have been published.
Hereditary multiple osteochondromas (HMO)
Multiple osteochondromas (cartilage-capped bony growths) arising from the area of the growth plate in the juxtaphyseal region of long bones or from the s... | [
"H Abdolrazaghi, A Riyahi, M Taghavi, P Farshidmehr, A Mohammadbeigi. Concomitant neurogenic and vascular thoracic outlet syndrome due to multiple exostoses.. Ann Card Anaesth. 2018;21:71-3",
"F Abdullah, R Kanard, D Femino, H Ford, J Stein. Osteochondroma causing diaphragmatic rupture and bowel obstruction in a ... | 3/8/2000 | 6/8/2020 | GeneReviews® | https://www.ncbi.nlm.nih.gov/books/NBK1116/ | [
"Review",
"Clinical Review"
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.